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GENERAL INTRODUCTION 
 
Group A Streptococcus (GAS), also known as Streptococcus pyogenes, is 
a Gram-positive bacterium that is strictly a human pathogen. While it can reside 
within the host carrier silently without causing symptomatic disease, it can also 
cause a wide array of diseases ranging from mild external infections, pharyngitis 
(‘strep throat’) and impetigo, to invasive infections such as necrotizing fasciitis 
(‘flesh-eating disease’) and streptococcal toxic shock syndrome. Moreover, it is a 
common cause of post-infection sequelae; acute rheumatic fever and acute 
glomerulonephritis, which is a leading cause of mortality due to invasive group A 
streptococcal infections. Globally, there are 600 million pharyngitis cases and 
1.78 million new cases of invasive GAS infection each year, causing at least 
500,000 deaths. In the United States alone, the medical burden caused by GAS 
infection is approximately 2 billion dollars annually [1].  Comparison of the 
epidemiology studies of invasive GAS infections occurring in the United States 
from1995-1999 to the more recent study between 2000-2004 revealed that the 
deaths from invasive GAS infection increased by 19% (from an average 1200 
deaths to 1435 deaths, respectively) [1-3]. This suggests that the infections are 
becoming more severe, which may be due to the bacteria becoming more 
virulent. The mortality in these studies was most often from cases of toxic shock 
syndrome, necrotizing fasciitis, and some complications from pneumonia, 
bacteremia and meningitis. S. pyogenes is classified by the M protein, an outer 
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membrane protein, referred to as the M serotype [4]. Even though certain 
serotypes are more frequently associated with an invasive infection, most of the 
serotypes can cause similar severity of disease. In spite of many research 
efforts, an effective vaccine for GAS has not yet been fully developed. With 
increasing evidence of more virulent strains and the appearance of antibiotic 
resistant streptococcus [5, 6], the GAS vaccine is an urgent need. Therefore, a 
more complete understanding of the molecular pathogenesis of GAS is required 
in order to ultimately develop a successful vaccine.  
 S. pyogenes is an extracellular pathogen that is also capable of invading 
host cells during infection [7-9]. The invasive diseases require a combination of 
host cell invasion and circumvention of the host immune response. S. pyogenes 
possesses several virulence factors that not only facilitate host cell invasion, but 
also suppress and surpass host immune mechanisms. The major surface 
proteins, M protein and fibronectin binding protein, along with a cell wall 
component, lipoteichoic acid, assist in bacterial adherence and internalization 
into host epithelial cells [10-13].  Several streptococcal proteases, Hyaluronidase, 
Streptokinase and the SpeB cysteine protease, are reported to cause tissue 
destruction and allow the spreading of bacteria throughout the host cells [14-16].  
Multiple GAS virulence gene products also function to overcome host 
immune mechanisms.  M protein also has the property of an antiphagocytic 
molecule against polymorphonuclear leukocytes (PMNs) and macrophages [10, 
17, 18]. C5a peptidase cleaves complement factors and inhibits complement 
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activation [19]. The bacterial exotoxins, streptolysin S (SLS) and streptolysin O 
(SLO), have a cytotoxic effect on both epithelial cells and neutrophils [20-23]. In 
addition to cell lysis and impairment of PMN-mediated killing of GAS, SLS also 
inhibits neutrophil recruitment to the site of infection [24]. In addition to SLS, a 
recently identified virulence factor, streptococcal protease (SpyCEP), inactivates 
CXC chemokines and inhibits the recruitment of neutrophils [25-27]. Another 
group of virulence factors are the streptococcal superantigens (SAgs). The 
superantigens function to non-specifically stimulate the activation of T-cells, 
causing a massive inflammatory response, which is a hallmark of streptococcal 
toxic shock syndrome [28].  
In order to survive in various sites of infection, the bacteria must be able to 
adapt to different physiological conditions inside the human host, especially when 
in the hazardous environments created by the host immune response. The 
production of virulence factors is metabolically costly for bacteria. Therefore, 
coordination of virulence factor production to specific environmental conditions is 
necessary. Many bacterial pathogens are equipped with two-component 
signaling systems to orchestrate virulence gene expression in response to host 
conditions.  
Two-component systems (TCSs) are a common mechanism used by 
prokaryotic cells to trigger an adaptive response to environmental changes in 
order to thrive and persist in a particular niche [29]. The TCSs are generally 
composed of a membrane sensor kinase that senses an environmental stimulus 
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and a cytoplasmic response regulator that governs the changes in gene 
expression at the transcriptional level. In Gram-positive bacteria, the sensor 
histidine kinase contains an extracellular domain, which is responsible for 
sensing the signal, and a conserved histidine residue, which is auto-
phosphorylated during activation by the environmental signal. The cognate 
response regulator contains a conserved aspartic acid, which receives the 
phosphoryl group from the sensor kinase. The phosphotransfer process induces 
conformational changes in the regulator protein, affecting the DNA binding 
domain (H-T-H domain), resulting in a change in gene expression, and ultimately 
affecting in cell physiology [30].  
There are 13 conserved two-component systems (TCSs) identified from 
the complete genome sequencing of M1, M3, M5, M6, M18 and M28 serotypes 
of S. pyogenes [31-37]. So far, only three Streptococcal TCSs have been studied 
extensively for their roles in the pathogenicity of the bacteria during host-
pathogen interactions. The FasBCA system mainly regulates expression of 
genes involved in adhesion and invasion of host cells, such as the fibronectin 
binding protein, streptokinase and SLS [38, 39]. The CovRS system (also known 
as CrsRS) negatively regulates genes encoding capsule (hasABC) and several 
exotoxins (skaA, sagA, and speB) [40, 41] along with 15% of the entire 
transcriptome [42]. Deletion of the covRS genes conferred a hypervirulent 
phenotype during infection of mice [42]. Moreover, CovRS also controls the 
genes that contribute to S. pyogenes resistance to the human antimicrobial 
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peptide, LL-37, as well as to bacterial survival under iron starvation [43]. The 
Ihk/Irr system upregulates several secreted proteins that are involved in 
resistance to PMN-mediated killing [44, 45].  Any mutations in these described 
TCSs would cause a change in virulence due to the loss of regulation required 
for resistance to the host immune response. Therefore, to fully understand the 
pathogenesis of S. pyogenes, it is important to not only study virulence factors 
but also understand how these virulence factors are regulated during host 
infection.  
The research presented in this dissertation analyzes the role of the S. 
pyogenes sal locus, a putative lantibiotic locus, in virulence.  We have data to 
support the hypothesis that the function of this locus has evolved from its 
originally identified function in the commensal S. salivarius from providing a 
competitive advantage while residing in a polymicrobial environment to 
supporting virulence of S. pyogenes in a pathological niche.  
Lantibiotics are bacteriocin-like inhibitory peptides that are ribosomally 
synthesized and produced exclusively by Gram-positive bacteria. Their unique 
structure contains lanthionine or methyl-lanthionine residues formed by the 
cross-linking of cysteine to either dehydrolamine or dehydrobutyrine [46, 47]. The 
mode of action of the peptide is as a bactericidal pore-forming toxin against 
closely related Gram-positive bacteria, providing an ecological advantage to the 
producing bacterium, especially those inhabiting competitive environments such 
as mucosal surfaces [48, 49]. There are common genetic components found in 
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most lantibiotic loci, which include a gene to encode LanA, the pre-lantibiotic 
peptide, which is modified and transported by LanM, modifying protein, and 
LanT, transport protein, respectively. To prevent the bactericidal effect of its own 
lantibiotic, this locus also encodes an immunity protein LanI or a specialized ABC 
transporter, LanEFG, providing an immunity function [47, 50-53]. The production 
of the lantibiotic is tightly regulated through the activation of a two-component 
signaling system, LanKR. The cognate lantibiotic also functions as a cell-density 
signaling molecule for the TCS similar to a quorum sensing system [52, 54]. 
Most Gram-positive bacteria that harbor lantibiotic loci are commensal 
bacteria. However, it has been reported that some pathogenic bacteria also have 
a lantibiotic locus that functions in virulence. The cytolysin locus in Enterococcus 
faecalis is also described as a lantibiotic locus. The activity of the cytolysin is 
targeted against both bacteria and eukaryotic cells. The cytolysin has a toxic 
effect against several cell types including phagocytic cells like neutrophils and 
macrophages [55]. This scenario provides evidence that bacteria can evolve to 
use the product of a lantibiotic locus for their advantage against the toxic 
environment inside the host.  
The sal locus is a lantibiotic locus encoding proteins that produce and 
regulate a type 1 lantibiotic, salivaricin A [56]. This lantibiotic was first identified in 
S. salivarius, a commensal bacterium, which is predominantly found in oral and 
pharyngeal sites. Salivaricin A has an inhibitory function against several 
Streptococci, such as S. mutans and S. pyogenes, which can inhabit the same 
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host sites [57, 58]. Interestingly, S. pyogenes also harbors the sal locus and has 
~85% homology to the sal locus of S. salivarius. However, S. pyogenes does not 
produce an active salivaricin A and is not immune to salivaricin A produced by S. 
salivarius [59]. Despite the lack of lantibiotic functions, the sal locus is highly 
conserved with >92% homology in all S. pyogenes serotypes sequenced. The 
retention and conservation of this locus, in the absence of lantibiotic production, 
suggests that the change in the function of the sal locus in S. pyogenes is toward 
bacterial fitness in a different ecological niche.  
Zebrafish has been used as an animal model for several bacterial infection 
models because it has both innate and adaptive immune response [60]. It is also 
an execellent model for necrotizing fasciitis due to the similar clinical pathology 
observed in human. A previous transposon mutagenesis screen [61] identified a 
mutant with a transposon inserted into the salK gene of the S. pyogenes sal 
locus. The salK gene encodes a putative histidine kinase of a TCS and when 
mutated in S. pyogenes is highly attenuated in the zebrafish infection model.  
This suggests a role for the sal locus in pathogenesis of S. pyogenes. In these 
present studies, we demonstrated how the sal locus contributes to resistance of 
S. pyogenes to PMN-mediated killing during host-pathogen interactions as well 
as the transcriptional analysis of sal locus in S. pyogenes. 
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CHAPTER 1 
 
THE ROLE OF THE SALKR TWO COMPONENT SYSTEM IN 
INTRACELLULAR SURVIVAL IN NEUTROPHILS 
 
ABSTRACT 
Streptococcus pyogenes can cause severe invasive diseases, in part, due to its 
ability to evade the host immune response. Immune evasion is facilitated by the 
adaptability of S. pyogenes to survive phagocytosis and killing by neutrophils. A 
previous mutagenesis screen identified the salK gene, which is required for 
virulence in a zebrafish infection disease model. SalK of S. pyogenes has the  
putative function of a histidine kinase of the salivaricin lantibiotic locus, and is 
located upstream of a response regulator, SalR, constituting a putative two-
component signal transduction system. The complete deletion of the salKR 
genes in S. pyogenes conferred a mutant strain that was highly attenuated in a 
zebrafish infection due to inability to survive killing by neutrophils. This resulted in 
an inability to survive in the blood stream and disseminate to the spleen. The 
attenuation of the ΔsalKR mutant in the neutrophil infection assays was a 
consequence of the sensitivity of the mutant to cell lysis by lysozyme.  A 
difference in cell wall modification processes between the wild type and the 
ΔsalKR strains was suggested by an overall net charge difference on the 
bacterial cell surface, which could result in lysozyme sensitivity. This difference 
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was SalKR dependent, suggesting that the SalR protein may function in 
regulation of the genes involved in physical changes on the cell surface. 
Furthermore, SalKR regulation may also be playing an important role in 
adaptation of S. pyogenes to the host while residing intracellularly in 
macrophages. After passage through macrophages, survival of the wild-type 
strain increased approximately ten-fold in a human neutrophil assay compared to 
survival without passage, whereas the survival of the ∆salKR strain was 
unchanged. These results suggest that SalKR may sense the host environment 
and respond by upregulating survival mechanisms.  
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INTRODUCTION 
 
S. pyogenes is exclusively a human pathogen that produces a number of 
virulence factors that allow it to survive and persist in host cells. The first line of 
defense of the host innate immune system that responds to most bacterial 
infections includes macrophages and polymorphonuclear neutrophils (PMNs). 
Several of S. pyogenes virulence factors inhibit and interfere with the microbial 
killing mechanisms used by these innate immune cells.  
 Resident macrophages residing in tissues are the first host immune cells 
that interact with S. pyogenes after the bacteria transition from mucosal sites to a 
tissue infection [62]. Resident macrophages have been shown to be able to 
phagocytose and kill S. pyogenes in a mouse model of infection [63]. The 
destruction of the bacteria occurs within the phagolysosome, which contains 
several antimicrobial agents including reactive oxygen species, nitric oxides, 
antimicrobial peptides and enzymes. The activated macrophages, after exposure 
to S. pyogenes, also play a role in recruiting inflammatory cells to the site of 
infection by secreting cytokines and chemokines.  Unregulated expression of 
these inflammatory mediators can result in septic shock, which worsens the 
outcome of the infection. During interaction with S. pyogenes, an unusual 
activation program of macrophages was observed. In addition to differential gene 
expression of cytokine production, the typical Nitric oxide synthase (iNOS) 
production was not induced. [64]. Therefore, only reactive oxygen species and 
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other antimicrobial peptides and enzymes in macrophages are responsible for 
controlling S. pyogenes infection.  
While several studies have shown that murine macrophages can 
efficiently kill S. pyogenes in vivo, there is evidence of intracellular survival of the 
bacteria in human monocyte-derived macrophages and during human soft tissue 
infection [65, 66]. Another role of macrophages may also be to serve as a 
reservoir for S. pyogenes during antibiotic treatment as a safe environment for 
replication and multiplication [65, 67]. Moreover, the ability to survive 
intracellularly in a macrophage may also allow the bacteria to disseminate from 
the primary site of infection, which has been observed in patients with severe 
invasive streptococcal infection from which the bacteria can be isolated from the 
blood stream [68]. The data presented in this study also suggests that                
S. pyogenes residing in macrophages upregulate gene products that provide 
resistance to subsequent neutrophil killing. 
 The role of neutrophils during S. pyogenes infection has been extensively 
studied. Human neutrophils have both intracellular and extracellular killing 
mechanisms for bacterial pathogens. After phagocytosis of the bacteria in the 
presence of complement factors, neutrophil phagosomes fuse with granules that 
contain several bactericidal agents including both oxygen-dependent and 
oxygen-independent molecules. The production of reactive oxygen species 
(ROS) is triggered by NADPH oxidase after bacterial ingestion. The difference 
between the ROS produced by macrophages and neutrophils is nitric oxide 
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production, which is only present in macrophages [69, 70]. Degranulation occurs 
during the fusion of the phagolysosome with azurophilic and secondary granules 
containing non-oxidative peptides and enzymes that have potent antimicrobial 
activity, such as defensins, cathepsins, lysozyme, elastase and cathelicidins. In 
addition to intracellular killing, neutrophils can kill bacteria extracellularly by 
releasing Neutrophil Extracellular Traps (NETs). The fiber-like structure of NETs 
is composed of antimicrobial granules and chromatin, which trap and kill the 
bacteria [71, 72]. 
S. pyogenes is also able to survive intracellularly in neutrophils, which 
allows the bacteria to survive in the bloodstream as well as disseminate to 
different sites of infection [73, 74]. Several virulence factors and the ability to 
adapt to a changing environment allow S. pyogenes to survive neutrophil killing 
mechanisms. DNase, secreted by S. pyogenes, degrades the secreted chromatin 
and allows bacteria to escape killing in NETs [75]. A regulator, PerR, of group A 
streptococcus is shown to assist in the survival of the bacteria under oxidative 
stress conditions [76]. S. pyogenes also becomes resistant to neutrophil cationic 
antimicrobial peptides and enzymes by modifying its cell wall. Addition of a D-
alanyl group onto the highly negatively charged lipoteichoic acid molecule on the 
cell wall reduces overall net charge on the bacterial cell surface as well as 
decreasing the attraction of cationic bactericidal peptides [77, 78]. Another 
streptococcal cell wall modification, O-acetylation of the C6 position on N-acetyl-
muramic acid of peptidoglycan, functions to block the host lysozyme cleavage 
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site, thereby conferring bacterial resistance [79]. In addition to the ability to 
survive neutrophil killing, intracellular bacteria also exhibited higher capsule 
production, creating a more virulent S. pyogenes [80]. Increased virulence from 
human leukocytes was observed when S. pyogenes is exposed to subinhibitory 
concentration of a human antimicrobial peptide, LL-37 [81]. These data suggest 
that an overall bacterial adaptation is required for the resistance to host immune 
responses. 
In this study, we demonstrate that the SalKR two-component system also 
has a function in pathogenesis of S. pyogenes, facilitating bacterial survival in 
human polymorphonuclear leukocytes and allowing bacterial dissemination. 
Moreover, we also observed a role for SalKR in a bacterial adaptation 
mechanism that was induced while residing in macrophages. This adaptation 
subsequently increased S. pyogenes resistance to human neutrophil killing 
suggesting a possible role for SalKR in global gene regulation. 
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MATERIALS AND METHODS 
  
Bacterial strains, media, and growth conditions. All plasmids were 
maintained in either Escherichia coli DH5α cells or E. coli TOP10 cells 
(Invitrogen), which were cultured aerobically in Luria-Bertani (LB) medium (BBL) 
supplemented with either 25 µg/ml kanamycin, or 20µg/ml chloramphenicol at 
37°C as required. The Streptococcus pyogenes M14 serotype, HSC5 [82, 83] 
strain, used in this study was cultured anaerobically in Todd-Hewitt medium 
(BBL) supplemented with 0.2% yeast extract (BBL) (THY medium) or THY 
medium supplemented with 2% proteose peptone (TP) (BBL), and incubated in 
15-ml conical tubes at 37°C under static conditions. Plasmids in S. pyogenes 
were maintained in media supplemented with 500 µg/ml kanamycin and 3 µg/ml 
chloramphenicol. S. pyogenes cultured on solid medium (THY supplemented 
with 1.4% agar) was incubated in an anaerobic gas chamber with GasPak (BBL) 
cartridges at 37°C. Mid-log phase cultures were grown by diluting overnight 
cultures of S. pyogenes 1:50 into fresh THY medium. When necessary,             
S. pyogenes mutants were selected on THY plates that contained 
chloramphenicol (Cam) (3 µg/ml), kanamycin (Kan) (500 µg/ml), or erythromycin 
(Erm) (1 µg/ml) as appropriate. 
 
Manipulation of DNA. Chromosomal DNA was purified from S. pyogenes as 
described previously [84]. Plasmid DNA was isolated using Pure Yield Plasmid 
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Mini Prep (Promega) and transformed into E. coli and S. pyogenes by 
electroporation as described previously [84]. Restriction endonucleases, ligases, 
and polymerases were used according to the manufacturers recommendations. 
When required, DNA fragments were purified using a gel extraction kit 
(Fermentas). 
Disruption of salKR. An inframe deletion of the salKR region was constructed 
by joining the 5’ end of the salK gene along with ~500 bp of sequence uptstream 
with the 3’ end of the salR gene along with ~500 bp of sequences downstream. 
The salK 5’ end region was amplified using primers; 5’-SalK-del-seg 1 (CTT CGA 
TTA GGT CAA GTG AAC C) and 3’-SalK-del-seg1-Sal1 (ACG CGT CGA CAG 
CTG CTG TAT CAA TAA GCG GTC). The salR 3’ end region was amplified 
using primers; 5’-SalKR-del-seg2-Sal1 (ACG CGT CGA CGT ATC CAA CTG 
TTA TTC CAA CAG) and 3’-SalKR-del-seg2 (GTC GTT TGA TTA TCT GCA 
ACT CAG). The PCR amplification products were digested and with SalI 
restriction enzyme (Invitrogen) and ligated together into the PCR 8/GW/TOPO 
vector and transformed into E. coli Top 10 cells (Invitrogen). The vector with sal 
sequences was then digested with SalI, ligated with a fragment containing a 
kanamycin containing SalI sites cut from vector pABG-5. The ligation product 
was transformed into E. coli cells to propagate plasmid vector containing 
kanamycin resistance cassette in between the 5’.end of salK and 3’ end of salR 
resulting in psalKR-del. The plasmid then was isolated and used as a template in 
PCR amplification of the salK-Kan-salR sequence using primers; 5’-salK-BamHI 
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(CGC GGA TCC GAG AGA ACC TGT CTC TTC and 3’-SalKR-del-seg2-PstI 
(AAA ACT GCA GGT CGT TTG ATT ATC TGC AAC TCA G). The PCR fragment 
was digested with BamHI and PstI and ligated to the suicide streptococcal vector 
pJRS233 [85, 86] and initially transformed into E. coli cells for plasmid 
propagation. The pJRS plasmid was then isolated and transformed into WT         
S. pyogenes HSC5 strain.  The recombination of the temperature sensitive pJRS 
vector resulted in replacing the WT salKR alleles during cycling of permissive to 
non-permissive temperature as described previously [86]. The ΔsalKR deletion 
was confirmed by PCR. 
 
Zebrafish infection assays. Zebrafish infection was performed as described 
previously [16]. An inoculum of 1 x 105 CFU of mid-log phase bacteria was 
injected intramuscularly into the dorsal muscle using a U-100 ultrafine insulin 
syringe with a 29-gauge needle (BD scientific). Minimums of 6 fish were infected 
per bacterial strain. The infected fish were placed in 400 ml beakers containing 
225 ml of sterilized double-distilled water with 60 mg/ml of aquatic salts (Instant 
Ocean). A ventilated plastic screen was also placed on the top of each beaker.  
The experiment was repeated at least 3 times.  
 
Histology of S. pyogenes infected zebrafish. The infected zebrafish were 
euthanized 24 hours post-infection.  Whole fish were fixed for 24 hours with 10% 
formalin in 15 ml tubes with rotation. Then the zebrafish were dehydrated by 
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several incubations with increasing concentrations of ethanol. After the final wash 
with 100% ethanol, the fish were incubated in toluene for 24 hours. Tissues were 
then placed in 60°C paraffin plus infiltration medium in tissue cassettes.  
Following a one hour incubation in a 60°C water-bath, the paraffin was changed 
and the fish was incubated for another 48 hours under the same conditions. The 
final incubation was done with paraffin only and then the cassettes were cooled. 
After solidification, the cassettes were stored in ice water containing a small 
amount of fabric softener. The fish were sliced into five-micron sections, and 
placed on microscope slides followed by H and E staining. 
 
Protease activity assays.  Proteolytic activity was examined by measurement of 
clearance zone on skim milk agar medium inoculated by stabbing the agar with 1 
µl mid-log phase bacteria normalized to 1 × 108 bacterial cells/ml. The agar 
plates were incubated at 37°C in an anaerobic environment for 24 hours. 
 
Dissemination of bacteria. Zebrafish were inoculated intramuscularly as 
described above. At 24-hour post infection, spleens were recovered from 
euthanized fish and aseptically homogenized. Homogenates were serially diluted 
and plated on THY plates to assess the number of live bacteria (CFU) from the 
spleen. A minimum of 8 spleens was tested per strain.   
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Whole Blood Assay. Heparinized blood was obtained from healthy volunteers 
by venapuncture and collected in BD vacutainers coated with 3.8% citrate. Mid-
log phase bacterial cells were added to 1 ml of blood to a final concentration of 
approximately 1.0 × 102 CFU/ml. Each strain was tested in duplicate. The 
suspensions were incubated on a rotator at 37°C for 3 hours. To determine 
bacterial viability, serial dilutions of the samples was made in PBS (Phosphate 
Buffer Saline) and plated onto THY plates. The plates were incubated overnight 
in a CO2 incubator at 37°C.  
 
Isolation of neutrophils from human whole blood. Neutrophils were isolated 
from heparinized blood collected as described above. Erythrocytes were 
separated by sedimentation in 6% dextran (MP-biomedicals), followed by 
separation of neutrophils using Ficoll-Hypaque (Pharmacia) density gradient 
centrifugation [87, 88]. Contaminating red blood cells were lysed with ddH2O for 
28 seconds and immediately neutralized with 1.8% NaCl (Fluka). The purified 
neutrophils were collected by centrifugation and resuspended in Dulbecco's 
modified Eagle medium (DMEM; Invitrogen) supplemented with 1% fetal bovine 
serum (FBS; Invitrogen) at an approximate final concentration of 
2.5×106 cells/ml. 
 
Serum collection. Blood was collected from healthy volunteers using BD 
Vacutainer glass serum tubes with no additives and allowed to clot completely for 
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at least 30 min. Samples were then centrifuged at low speed for 5 min and serum 
was gently collected from the tubes. 
Neutrophil killing assay. Extracellular neutrophil killing was analyzed by 
incubating mid-log phase bacterial cells with 106 neutrophils at an MOI of 1 in a 
total volume of 1 ml DMEM supplemented with 1% FBS. The mixtures were then 
incubated on a rotator at 37°C. Viable bacterial counts were determined by 
plating serial dilutions of aliquots collected at 0, 1, 2 and 3 hour time points. To 
determine intracellular neutrophil killing, DMEM was supplemented with 50% 
human serum. Percent bacterial survival was calculated as follows; (number of 
bacteria with neutrophils /number of bacteria without neutrophils) x 100. All 
assays were performed in duplicate for each time point and repeated at least 3 
times.  
 
Cytospin preparations of Neutrophil assays. After a 3 hour incubation of the 
bacteria with neutrophils in the conditions described above, 100 ul of the 
neutrophil assay was placed into a cytospin column with a glass microscope slide 
and centrifuged at 700 rpm for 5 min. Then the slides was visualized by staining 
using DiffQuik (Fisher).  
 
Antimicrobial assay. Overnight cultures were transferred into fresh THY 
medium and allowed to grow to an approximate OD600 of 0.300. Normalized 
cultures (OD600 of 0.300) were collected and washed twice with PBS and 
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resuspended in 1ml PBS. Antimicrobial peptides were dissolved in the 
appropriate solvent at the following working concentration and then added to 
THY medium individually at the final concentration of Carbenicillin 1µg/ml, 
Erythromycin 1 µg/ml and Nisin 100 µg/ml. In a 96-well plate, 2-fold serial 
dilutions of the THY medium with antimicrobial peptides were made using THY 
medium. Then 4 µl of normalized cultures were inoculated into each well. 
Following overnight incubation in 5% CO2 at 37°C, bacterial growth was 
determined by measuring OD600 using a plate reader (VersaMax). 
 
Hydrogen Peroxide sensitivity assay. Bacterial cultures were grown in THY 
medium individually to mid-log phase. A 50-µl normalized culture (1x106 cells/ml) 
was spread evenly over the surface of a THY agar plate using a sterile cotton 
swab. Ten microliters of 3%, 0.3%, 0.03% or 0.003% H2O2 was added to the 
center of a 10mm diameter sterile disk made from blotting paper and placed at 
the center of each plate. After incubation at 37ºC for 16 hours in 5% CO2, the 
zone of growth inhibition was measured. The experiment was repeated at least 3 
times with duplicate plates of each H2O2 concentration and each bacterial strain. 
The bacterial growth in the presence of H2O2 was assessed in 96-well plate by 
inoculating 4 µl the normalized mid-log cultures in 196 µl of THY broth containing 
one of the H2O2 concentrations described above. After 3 hours incubation at 
37ºC with 5% CO2, the samples were serially diluted in PBS and plated to 
enumerate the colony forming units of bacteria.  
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In vitro Lysozyme sensitivity assay. Chicken egg white lysozyme (Sigma) was 
added to TE buffer at a stock concentration of 200 mg/ml. Bacterial cultures at 
mid-log phase were normalized to OD600 of 0.300 then inoculated 1:100 into 
fresh THY broth containing a concentration range of 5-25 mg/ml of lysozyme 
(range of 10,000-100,000 enzymatic units) and incubated at 37ºC with 5% CO2. 
The OD600 was measured every hour for 8 hours to obtain a growth curve in the 
presence of lysozyme. A separate set of samples were serially diluted and plated 
to enumerate surviving bacteria (CFU) at the 3 hour time point. 
 
Macrophage infection. Murine macrophage cells (RAW 264.7) were seeded at 
1 × 106 cells/ml per well into a 24-well plate and allowed to adhere overnight in 
5% CO2 incubator at 37°C. The following day, cells were washed three times with 
PBS and incubated with log-phase bacteria cells in DMEM supplemented with 
10% FBS at 1 × 106 CFU/ml per well, a multiplicity of infection (MOI) of 1. The 
plate was then incubated for 1 hour at 37°C in a 5% CO2 incubator. Following 
incubation, each well was washed 5 times with PBS to remove non-adherent 
bacteria. The infected RAW cells were incubated for an additional hour in fresh 
DMEM plus 10% FBS with added 100 µg/ml gentamicin (Invitrogen) to eliminate 
extracellular bacteria. After the gentamicin treatment, each well was washed 
three times with PBS and fresh DMEM plus 10% FBS containing no antibiotic 
was added. At the 24-hour time point, aliquots were taken from the supernatants 
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and cells were lysed by the addition of 1 ml of sterile double-distilled water. The 
lysate was serial diluted in PBS and plated for determination of live bacterial cells 
after 24 hours in macrophages. 
 
Cytochrome C binding assay. The cytochrome C binding assay was performed 
as previously described [77] with minor changes. Overnight cultures were diluted 
1:100 into fresh THY medium and allowed to grow at 37ºC to OD600 ~ 0.7. After 
all cultures were normalized, 10 ml of each culture was centrifuged and 
resuspended in 1 ml of 20 mM MOPS buffer pH 7.0 with 0.5 mg/ml of 
cytochrome C. After incubation for 10 min at room temperature, the samples 
were centrifuged at 16,000 x g for 5 min. The supernatant was collected without 
disturbing the cell pellet and then cytochrome C absorption was measured at 
OD530. The percent cytochrome C captured was calculated by comparing to a 
cytochrome C absorption control without bacterial cells.  
 
Dot plate method for bacterial viability. The Dot plate method was used as 
described previously [89] with minor modifications. One hundred microliters of 
sample was loaded into the first well of each row of a 96-well plate, and 10-fold 
serial dilutions were made using a multichannel pipette by transferring 10 µl from 
the first well (n) into 90 µl of medium in the next well (n+1) of each row, mixing by 
pipetting up and down 10 times, and repeating the process with pipette tips 
changed between dilutions. Following the dilution, 10 µl from each of the five 
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selected dilutions were plated in three replicates onto an agar plate using a 
multichannel pipette. The plates were allowed to dry completely before being 
incubated overnight in a 5% CO2 incubator at 37°C.  Colony counts were 
performed manually on the dilutions that showed individual separated colonies. 
 
Neutrophil assay after the bacterial passage through macrophages. Mid-log 
phase cultures were normalized to an OD600 of 0.3 and used to infect 
macrophages (RAW) as described above. The bacterial cultures were also 
inoculated into DMEM supplemented with 10% FBS along with the macrophage 
infection as a control. The inoculums were also serial diluted and plated to 
enumerate the number of bacteria with a 6X6 dot plate method [89]. Following a 
24 hour incubation, both the control macrophages and the infected macrophages 
were collected to use as a inoculum for the neutrophil assay. The bacterial cells 
were normalized to 1 × 106 CFU/ml and incubated with neutrophils as described 
in the neutrophil assay above. 
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RESULTS 
The SalKR two component signaling system of the sal locus has an 
important role in virulence. One of the highly attenuated mutants isolated in a 
previous transposon mutagenesis screen [61] was found to have an insertion in 
the salK gene, encoding a putative histidine kinase, in the salivaricin locus  
(figure 1). When co-injected with the wild type strain, the competitive index (CI) 
for the salK (Ωtnp) mutant strain was 0.02. The LD50 of the salK insertion strain 
was 1x105, which was approximately 2 logs higher than the wild-type strain. SalK 
is part of a putative two-component signaling system, which is coupled with its 
putative regulatory protein, SalR. To further investigate the role of SalKR in 
virulence, an in-frame deletion of the salKR genes in S. pyogenes-M14 was 
constructed using a streptococcal suicide plasmid, pJRS233 [86]. A non-polar 
kanamycin resistance cassette was left in place of the salKR genes.  Analysis 
was performed to confirm that the ΔsalKR strain was not defective in growth in 
several media including THY, TP, DMEM+10%FBS and chemically defined 
media (CDM) (data not shown). In addition, the ΔsalKR strain displayed the 
same hemolytic phenotype as WT when grown on a blood agar plate (data not 
shown). However, similar to the salK transposon insertion strain, the ΔsalKR 
strain is 50% less virulent compared to the WT strain during a zebrafish infection 
assay (figure 2). The lesion observed in the zebrafish infected with the ΔsalKR 
strain was much smaller than that of wild-type and healed within 3 days (data not 
shown). The histological examination of the dorsal muscle tissue of fish at 24 
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hours post-infection showed similar destruction of tissue between the wild type 
and ΔsalKR infection (figure 3). The activity of the secreted SpeB protease 
produced by the bacteria was examined using skim milk agar medium. The 
measured zone of clearance showed no difference in the protease production 
between wild type and the ΔsalKR strain (figure 4). However, the tissue necrosis 
from the ΔsalKR infection seemed to be limited and slightly more infiltration of 
inflammatory cells was observed (figure 3). Analysis of dissemination to the 
zebrafish spleen at 24 hr post intramuscular (IM) injection showed that the 
ΔsalKR strain had 2 logs less colony forming units (cfu) compared to the WT 
strain (figure 5). The lower dissemination profile compared to WT suggested that 
the ΔsalKR strain may be unable to initiate a successful infection due to an 
inability to survive at the site of infection and/or in the blood stream. 
	   26	  
 
Figure 1. Sal locus gene structure and orientation of S. pygenes strain HSC5 serotype 




Figure 2. Survival curve of zebrafish infection. Attenuation of ΔsalKR in zebrafish 
infection assay. Percent survival of zebrafish infected with media (diamond), ΔsalKR 
mutant (triangle), salK (Ωtnp) mutant (circle) and WT (square) strains. Percent survival 
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Figure 3. Histology of (IM) infected zebrafish dorsal muscle at 24 hours post infection. 
Images in column A were from the non-infected fish. Images in column B were from the 
fish infected with wild type S. pyogenes. Images in column C were from the fish infected 
with the ΔsalKR mutant. The white arrowheads indicate zebrafish immune cells. The 
black arrows indicate the bacteria cells. All samples were stained using a standard H 
and E staining protocol. The top row images are at 40X magnification and the bottom 
row images are at 100X magnification.  
 




Figure 4. SpeB proteolysis assay. The zone of clearance detected on skim milk agar 
medium. Image A is the agar inoculated with wild type S. pyogenes, B is the ΔsalKR 
mutant and C is the Δrgg mutant that lacks SpeB cysteine protease activity. 
 




Figure 5. The dissemination of the bacteria to the spleen. Bacteria number (CFU) 
enumerated from the spleen of fish infected with the wild type or the ΔsalKR mutant 
strain. Columns represent the average CFU recovered from spleen with standard 
deviations of four independent experiments with 6 fish per strain per experiment.            
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Attenuation of the ΔsalKR mutant strain in the presence of human immune 
factors. To test the ability of the mutant strain to survive in blood, we performed 
a human whole blood assay and observed that the ΔsalKR strain was attenuated 
for growth by 1 log compared to wild type growth in whole blood (figure 6). This 
suggests that the SalKR proteins play an important role in survival in the blood 
stream, which ultimately leads to successful dissemination. Since neutrophils are 
the predominant non-specific immune cells in the blood stream, the attenuation 
of the ΔsalKR strain could be due to an increased susceptibility to neutrophils. To 
test this hypothesis, neutrophils freshly isolated from human whole blood were 
used in a neutrophil killing assay at a 10:1 ratio of neutrophils:bacteria. Stained 
cytospin preparations made from the neutrophil killing assays show that in the 
presence of neutrophils with 50% human serum both the ΔsalKR and wild-type 
strains are intracellular in the neutrophils (Figure 7).  However, intracellular 
survival of the ΔsalKR strain was 30% less than observed with the wild-type 
strain (figure 8) with 70% of the bacteria killed within 1 hour of incubation (data 
not shown). The serum conditions used in this assay (50% serum) mimic the 
conditions found in the bloodstream.  Therefore, the SalKR proteins are playing a 
role in S. pyogenes survival in the bloodstream through protection from 
intracellular killing by neutrophils. In the absence of serum, similar to conditions 
found in the tissue, both the wild-type and ΔsalKR strains were found to be 
extracellular in the neutrophil killing assay (Figure 7). While the wild-type strain 
actually grew in this assay (>100% survival), the ΔsalKR strain survived to only 
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approximately 70% of the original inoculum, demonstrating extracellular killing by 
neutrophils (figure 8). This suggests that the SalKR proteins are also important in 
survival from extracellular killing by neutrophils, which is evidenced by the 
attenuation of the ΔsalKR strain at the site of infection. Collectively, these data 
demonstrate that the SalKR proteins are important in survival from both 
intracellular and extracellular killing by neutrophils. One of the extracellular killing 
mechanisms used by neutrophils is the release of chromatin in combination with 
azurophilic granule proteins that contain antimicrobial peptides and proteins, also 
known as Neutrophil Extracellular Traps (NETs) [71, 72]. The chromatin structure 
traps and prevents bacteria from spreading and also serves as a means to 
deliver concentrated microbicidal enzymes and peptides to the site of infection.  
DNases or endonucleases produced by Streptococcus species allow the bacteria 
to escape NETs killing [75, 90].  DNase was added to the neutrophil killing 
assays to determine if destruction of the chromation in the NETs would allow the 
ΔsalKR strain to escape and survive the extracellular killing to the level of the 
wild type strain. However, we observed no significant survival increase of the 
mutant (data not shown).  Since the assays were performed in a small volume 
with rotation (see materials and methods) the neutrophil secreted antimicrobial 
peptides or enzymes would still come into contact with the bacteria and therefore 
may be responsible for the decreased percent survival of the ΔsalKR strain. 
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 Neutrophils secrete a large number of enzymes and antimicrobial 
peptides [69, 70]. To determine if the SalKR proteins are involved in a 
mechanism that confers a non-specific resistance to antimicrobial peptides, the 
susceptibility of both the wild type and ΔsalKR strains to several bacterially 
derived antimicrobial peptides, nisin, gramicidin, carbenicillin and polymyxin B, 
was tested (data not shown). We found no significant difference in susceptibility 
to the antimicrobial peptides tested. Similarly, results from a hydrogen peroxide 
sensitivity test demonstrated that both the wild type and the ΔsalKR mutant are 
resistant to oxidative killing to the same level (data not shown). These results 
suggest that the attenuation of ΔsalKR strain is not due to an increased 
susceptibility to oxidative radicals or involved in a non-specific antimicrobial 
resistance mechanism. 
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Figure 6. Whole blood assay with 100 bacterial cell inoculum. Data represent the 
average bacterial CFU grown in human blood for 3 hours with standard error. Average of 



















Figure 7. Cytospin preparations from the neutrophil assay. Images A and B are 
neutrophils with wild type, A) with serum and B) without serum. Images C and D are 
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Figure 8. Neutrophil assay. Percent survival of enumerated bacteria recovered from      
3-hour incubation calculated relative to control without neutrophils. The columns 
represent the mean value of percent survival of bacteria relative to control without 
neutrophils with standard deviation of three separate experiments. (*, P value < 0.05)   
(**, P value < 0.01; two-tailed t test).  
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The ∆salKR mutant strain is highly sensitive to lysozyme activity. Both 
intracellular and extracellular killing mechanisms of neutrophils involve 
degranulation and delivery of azurophilic granules. Lysozyme is the major 
microbicidal enzyme in the neutrophil granules [91]. Therefore the growth of the 
ΔsalKR and wild type strains was assessed in the presence of lysozyme by 
measuring the culture density of normalized mid-log phase cultures incubated 
with multiple concentrations of lysozyme for 16 hours. Results indicated that the 
ΔsalKR strain is highly sensitive to lysozyme treatment compared to the wild type 
strain (figure 9A). The ΔsalKR strain was growth inhibited starting at 50,000 
lysozyme enzymatic units while the wild type strain was still able to grow at the 
highest concentration tested, 100,000 units of lysozyme. The viability of strains 
growing in lysozyme in the previous assay was tested by plating bacteria at the 
concentrations that showed little to loss of culture density, 40000, 50000, and 
60000 units. The CFUs from the ΔsalKR strain were significantly (P value = 
0.018, 0.0004 and 0.0001 respectively) less (~ 2 logs) at 30,000-lysozyme 
enzymatic units and more than 3 logs less at 50,000-enzymatic units (figure 9B).  
 




Figure 9. Lysozyme assay. Sensitivity of the ΔsalKR strain to lysozyme treatment. A) WT 
(blue bar) and ΔsalKR (orange bar) cells were grown in THY broth with increasing 
amounts of lysozyme enzymatic units. The OD600 was measured after 16 hours of 
incubation at 37ºC in 5% CO2. B) The number of viable bacteria grown for 3 hours in 
THY broth in the presence of lysozyme at 40,000-60,000 enzymatic units. (*, P value < 
0.05) (**, P value < 0.01; two-tailed t test).  
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The wild type and ΔsalKR strains differ in cell wall charge. Since an 
increased sensitivity to lysozyme can indicate a cell wall modification, the wild 
type and ΔsalKR strains were subjected to a cytochrome C binding assay to 
determine if the overall surface charge of the cell wall was the same between the 
two strains. Without cell wall modifications, the anionic property of lipoteichoic 
acid would allow more binding of the positively charged cytochrome C to 
bacterial cells. If the cell wall were modified, for example by D-alanylation, overall 
ionic charge would become more neutral resulting in less binding to cytochrome 
C. When grown in THY media, the ΔsalKR strain showed less cytochrome C 
bound than that of the wild type strain, implying that the cell wall of the ΔsalKR 
strain has less anionic charge than the wild type cell wall (figure 10). However, 
when the wild type and ΔsalKR strains were subjected to the cytochrome C 
assay after being collected from an infection of a murine macrophage cell line, 
the wild type strain showed a reduced anionic charge on the cell wall surface, as 
illustrated by binding less cytochrome C, while the ΔsalKR strain showed no 
change (figure 10). This suggests that the SalKR proteins may be involved in 
regulation of cell wall modifications. 	  
	   39	  
	  
Figure 10. Cytochrome C binding assay. Binding of Cytochrome C to bacteria comparing 
WT (blue bar) to ΔsalKR (orange bar) that were grown in THY broth or murine 
macrophage cell line (MΦ). The data represent percent cytochrome C captured relative 
to control (THY control or MΦ cells control). The standard deviations were calculated 


























	   40	  
Passage through macrophages increases resistance of S. pyogenes to 
Neutrophil killing. The cell wall modification of the wild type strain during 
macrophage infection suggested there may be an adaptation of the bacteria 
while residing intracellularly in macrophages. This modification was not observed 
in the ΔsalKR mutant strain. To test if the adaptation could result in increasing 
resistance of S. pyogenes to the host immune response, the neutrophil assay 
was performed using bacteria collected from a macrophage cell lysate after 24 
hours of infection. The number of bacteria recovered from the in vitro 
macrophage infection was not different between the wild type and ΔsalKR strains 
(figure 11). However, after the neutrophil assay, the percent survival of the wild 
type strain from neutrophil killing increased to 19% compared to the control at 
2%, whereas with the ΔsalKR strain, percent survival stayed the same as the 
control, ~2% (figure 12). As a control, the Ua1 mutant strain, which contains the 
same Kanamycin resistance cassette as the ΔsalKR strain, was shown to be 
similar to the wild type strain by an increase in resistance to neutrophils.  The 
increase in resistance to neutrophil killing observed here was therefore SalKR 
dependent.   
 




Figure 11. Macrophage infection. Bacteria recovered from murine macrophage tissue 
culture assay. At 24 hours post gentamicin treatment, the bacterial cell numbers 
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Figure 12. Neutrophil assay with serum. Percent survival of bacteria from neutrophil 
assay after the bacteria are passaged through the murine macrophage cell line. The 
open bars represent the neutrophil assay with bacterial cultures grown in DMEM + 10% 
FBS for 24 hours. The filled bars represent the neutrophil assay with bacterial cultures 
collected from 24-hour post gentamicin treatment of a macrophage infection. Percent 
bacterial survival was calculated as follows; (number of bacteria with neutrophils 
/number of bacteria without neutrophils) x 100. (*, P value < 0.05) 
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DISCUSSION 
 
Bacterial pathogens must have mechanisms to respond quickly in order to 
adapt and survive the harsh environment created by the host immune response. 
The bacteria concomitantly adjust their growth to the nutrients present as well as 
their defense mechanisms to the host innate immune system. The coordinate 
changes in expression of metabolic and virulence genes in response to a drastic 
change of environment are orchestrated by two-component regulatory systems. 
During S. pyogenes interaction with human neutrophils, an immediate ~2 fold 
upregulation in expression of the Ihk-Irr two component regulatory system was 
observed within 30 minutes, with an overall differential gene expression resulting 
in changes in virulence, stress response and cell wall biosynthesis [45]. The irr 
mutant strain was severely attenuated in virulence in a mouse soft-tissue 
infection model. Several genes that are involved in cell wall modification were 
down-regulated in the irr mutant strain resulting in sensitivity to neutrophil 
antimicrobial peptides targeting the bacterial cell wall [44]. S. pyogenes CovRS is 
another two-component system that is involved in global gene regulation during 
host-pathogen interactions and contributes to bacterial pathogenesis [92-94]. The 
CovR response regulator was shown to modulate gene expression during 
bacterial growth in human blood and in a macaque pharyngitis model [95, 96].  
Therefore multiple global regulators function to coordinate expression of required 
virulence factors during interactions with the host.  	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In this study, we identified the virulence function of SalKR, one of the 13 
two-component systems identified in S. pyogenes. While the putative functions of 
SalK and SalR are a sensor kinase and a response regulator, respectively, 
involved in controlling the production of a lantibiotic, the salK transposon mutant 
(salKΩ) along with the ΔsalK and ΔsalKR deletion mutants were highly 
attenuated in the zebrafish infection model. The mutants were unable to cause 
the muscle necrosis observed during an infection with the wild type strain, 
suggesting that the mutants are attenuated for an invasive infection and therefore 
succumb to clearing by the host immune response.  This was supported by the 
results of the dissemination assay in which the salKR mutant strain demonstrated 
~2 logs less cfu recovered from the spleen at 24 hours post infection, suggesting 
that this strain was attenuated for an invasive infection.  
Clinical features of invasive Group A streptococcal infection include 
destruction of tissue and rapid systemic spread, resulting in bacteremia and toxic 
shock [65, 97]. In this study, histology of infected tissue showed similar tissue 
destruction between the wild type and ΔsalKR infections with a slight difference 
in immune cell infiltration. Biopsies from patients with invasive streptococcal 
infection revealed high bacterial loads with a concomitant high expression of the 
SpeB streptococcal cysteine protease [65, 98]. Analysis of SpeB activity by 
casein proteolysis revealed no difference between the wild type and the ΔsalKR 
mutant strain. These data, along with the similar histology at the site of infection, 
suggest that the attenuation of the ΔsalKR mutant may be due to the inability of 
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the mutant to disseminate. Bacterial dissemination requires mechanisms of 
resistance to the host immune response both at the site of infection and in the 
bloodstream. In the present study, the ΔsalKR mutant cannot survive in a whole 
blood assay suggesting that the function of SalKR is required during exposure to 
whole blood. This hypothesis is supported by the microarray analysis of             
S. pyogenes during growth in human whole blood showing that the salR gene 
was upregulated ~50 fold as early as 30 min after exposure to blood [99]. While 
whole blood is a rich nutritive environment, immune components are also present 
including opsonizing antibodies and complement components that facilitate 
phagocytosis of the bacteria by neutrophils (predominant immune cells in the 
bloodstream). Previous reports demonstrate that S. pyogenes can survive 
intracellularly in macrophages and neutrophils, which facilitate systemic spread 
of the bacteria [65, 74, 80]. In this study, the ΔsalKR mutant was able to survive 
intracellular killing in murine macrophages but not intracellular or extracellular 
killing by neutrophils. Therefore the attenuation of the ΔsalKR strain is due to the 
inability to survive neutrophil killing, suggesting that the function of SalKR 
involves a protective response to host immunity. However, we have been unable 
to complement the deletion mutant with a plasmid containing the salKR genes 
expressed from a constitutive promoter, suggesting that salKR expression must 
be differentially regulated, which is further discussed in the following chapter.  
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In spite of effective bacterial killing from production of reactive oxygen 
species (ROS) by neutrophils, the H2O2 assay showed that the ΔsalKR mutant 
strain has the same level of sensitivity to ROS as that of the wild type strain. 
SalKR function therefore involves resistance to oxygen-independent effectors of 
neutrophils. The ΔsalKR mutant is attenuated in both intracellular and 
extracellular killing by neutrophils. In this study, we demonstrated that the 
attenuation of the mutant is due to sensitivity to lysozyme, which is present in all 
granules in neutrophils and is involved in both intracellular and extracellular 
killing [69, 71, 100]. 
Lysozyme has muramidase activity, which enzymatically hydrolyzes the β-
1,4 glycosidic bond between N-acetyl glucosamine and N-acetyl-muramic acid of 
the peptidoglycan structure of the Gram-positive bacterial cell wall. The cleavage 
of the glycosidic backbone of peptidoglycan results in degradation of the cell wall, 
which leads to bacterial lysis. Moreover, lysozyme has a cationic anti-microbial-
peptide (CAMP) function, similar to antimicrobial peptides that destabilize 
bacterial cell membranes without muramidase activity [101]. After testing the 
sensitivity to several cationic antimicrobial peptides and antibiotics, the ΔsalKR 
mutant exhibited the same level of resistance to cationic antimicrobial peptides 
as the wild type strain indicating that the function of SalKR may be involved in the 
resistance to muramidase activity. Despite the presence of lysozyme in 
macrophages, both the wild type and ΔsalKR strains are able to survive at the 
same level in our murine macrophage infection while the mutant is highly 
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sensitive to human-neutrophil killing and chicken egg-white lysozyme. The 
difference detected could be due to the differences observed between a 
macrophage and neutrophil infection.  Previous analyses showed that the 
bacteria reside in the cytoplasm in macrophages [61] and may never be in a 
phagosomal compartment. In this study, we observe bacteria within phagosomal 
vacuoles in neutrophils. Since S. pyogenes are not in phagosomes in 
macrophages, they may never encounter lysosomal activity in this environment. 
In contrast the bacteria is most likely bombarded with lysozyme both 
intracellularly and extracellularly during a neutrophil infection.  
Several Gram-positive pathogens have evolved resistance mechanisms to 
the muramidase activity of lysozyme. Bacterial cell wall modification that works to 
block lysozyme access to its target cleavage site appears to be a common theme 
among lysozyme resistant bacteria. N-acetylglucosamine deacetylase (PgdA) is 
an enzyme that functions in cell wall modification in S. pneumoniae [102]. O-
acetylation at the C-6 position of N-acetyl muramic acid by O-acetyltransferase 
(OatA) is utilized by S. aureus [103, 104]. The same C-6 position can also be 
covalently linked to wall-teichoic acids (WTAs), which is facilitated by 
undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase (TagO) 
[105].  OatA and TagO are required for cell wall modification in S. aureus to 
become resistant to lysozyme [106]. In S. pyogenes, it has been shown that D-
alanylation of teichoic acids increased bacterial resistance to antimicrobial 
peptides and contributes to neutrophil survival [77].  D-alanylation is a process 
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that reduces the negative charge of lipoteichoic acid, which is a component in the 
Gram-positive bacterial cell wall. Subsequent reduction of overall net charge on 
the cell surface can decrease the affinity for cationic antimicrobial peptides as 
well as the susceptibility to the muramidase activity of lysozyme [77]. The S. 
pyogenes M14 strain HSC5, used in our study, possesses all the genes 
necessary for the cell wall modifications mentioned above, suggesting that S. 
pyogenes is capable of cell wall modification to become resistant to lysozyme. In 
this study, we briefly investigated the overall net charge of the cell wall 
comparing the ΔsalKR mutant to the wild type strain and the difference observed 
indicates that there is a dissimilarity in cell wall modification between the mutant 
and the wild type strain.  As a regulatory protein, SalR may be involved in this 
process by regulating the genes involved in physical changes on the cell surface. 
Further analyses are necessary to determine the role of SalKR in cell wall 
modification. 
Notably, we also observed an alteration in overall net charge on the 
bacterial cell surface during S. pyogenes wild type in vitro infection of murine 
macrophages. However, the cell wall modification does not occur in the ΔsalKR 
mutant suggesting that SalKR may regulate the cell wall alteration in response to 
the host immune environment. This physical adaptation would allow the bacteria 
to become more resistant to host antimicrobial mechanisms. In our study, wild 
type S. pyogenes that had been passaged through murine macrophages for 24 
hours increased its resistance to neutrophil killing while the ΔsalKR strain did not. 
	   49	  
The Ua1 strain is also a mutant that contains the Kanamycin resistance gene 
cassette, similar to ΔsalKR, but behaved as the wild type strain in response to 
neutrophil infection. Therefore the adaptation observed with the wild type and 
Ua1 strain is SalKR dependent. There is also evidence of S. pyogenes adapting 
while residing intracellularly in neutrophils resulting in increased bacterial 
virulence [80]. One particular study showed that after 48 hours in vivo while 
intracellular in PMNs the bacteria undergo phenotypic switching and become 
more virulent with higher capsule production and better survival in blood [80]. 
Previous reports have demonstrated that bacterial virulence of S. pyogenes and 
S. pneumoniae can be enhanced by serial passage in animals, blood, organs or 
tissue cultures [107-109]. Notably, the percent survival in neutrophils observed in 
this study after passage through macrophages was relatively lower than the initial 
neutrophil assay. The dissimilarity may be due to the growth phase difference of 
the bacterial inoculum. The initial neutrophil assay uses mid-log bacteria grown in 
THY culture medium, but the bacteria are most likely in stationary phase after 24 
hour infection of macrophages.  S. pyogenes virulence during different growth 
phases is not well understood. Nevertheless, regardless of growth phase, there 
is a clear difference in survival in PMNs of the wild type strain compared to the 
ΔsalKR mutant strain after passage through macrophages, suggesting a clear 
role for SalKR in this process.  Further analysis to determine the conditions in 
which the salKR genes are expressed in relation to growth phase is required for 
a better understanding of the SalKR role in bacterial adaptation. 
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In conclusion, the adaptation of S. pyogenes to the host environment is 
essential for its pathogenesis. The key players for this role are the two-
component regulatory systems that control and regulate gene expression in 
response to environmental cues. In this study we demonstrated that the SalKR 
two component system plays an important role in S. pyogenes virulence through 
either direct or indirect regulation of bacterial protective response genes. As 
several lantibiotic and/or bacteriocin loci have been shown to be involved in 
bacterial virulence, this study provides another example of bacterial evolution 
through alteration of the original function of genetic loci to facilitate bacterial 
fitness in its environmental niche. 
 
 
	   51	  
CHAPTER 2 
 
 TRANSCRIPTIONAL ANALYSIS OF THE SAL LOCUS AND THE 
REGULATORY ROLES OF SALKR AND SALA 
 
ABSTRACT 
The sal lantibiotic locus has an important role in virulence of Streptococcus 
pyogenes. Analysis of transcriptional regulation of this locus will provide a better 
understanding of the function of the sal locus in S. pyogenes pathogenesis. 
Transcriptional analysis of the S. pyogenes sal locus identified two possible 
promoters, one located upstream of the operon and another located upstream of 
salKR genes. The upstream salA promoter provided a read through transcript for 
the entire locus and was unaffected by the regulatory role of the SalR protein. 
The downstream salKR promoter had lower activity and different growth phase 
regulation compared to the salA promoter, suggesting regulation independent 
from the salA promoter. Use of a reporter construct to measure promoter activity 
revealed that the salKR promoter contains repression sites located upstream and 
downstream of the promoter elements, which are regulated by direct binding of 
the SalR protein as shown by EMSA analysis. Moreover, approximately two-fold 
higher expression of the salKR promoter is also observed in the salA deletion 
strain indicating the SalA peptide may function as an intracellular signaling 
molecule or co-repressor on the salKR promoter. This is the first study to 
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demonstrate the repression role of SalR and SalA towards salKR promoter 
expression and the first to describe the exact promoter locations for the sal locus 
in S. pyogenes.  
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INTRODUCTION 
 
Lantibiotics are produced exclusively by several species of Gram-positive 
bacteria. The mode of action of these peptides is to inhibit growth of other Gram-
positive bacteria. Therefore it is crucial for the transcription of these loci to be 
tightly regulated to ensure the production of the peptides along with the self-
immunity proteins to the cognate lantibiotic at the appropriate times. Regulation 
of lantibiotic production occurs at the transcriptional level through a regulatory 
protein that is activated by its cognate signaling kinase through phosphorylation 
as part of a two-component regulatory system.  The genetic structure of a 
lantibiotic (lan) locus generally includes genes for the lantibiotic pre-peptide 
(lanA), posttranslational modification enzymes (lanM), a transport protein (lanT), 
an immunity protein(s) (lanI or lanFEG) and a two-component regulatory system 
(lanKR) [47, 110, 111]. The organization of the lantibiotic structural genes has no 
particular order or orientation, whereas the promoters that regulate the gene 
expression are commonly located upstream of lanA and lanKR, and in some 
cases, upstream of lanI or EFG [47, 110].  
Biosynthesis of a lantibiotic locus is autoregulated by the cognate 
bacteriocin via interaction with LanK of the two-component signaling transduction 
system, resulting in transcriptional activation. The activation of the promoter is 
through direct DNA binding of the regulator LanR to the pentanucleotide-direct-
repeat binding site located between -39 to -24 upstream of -10 promoter region 
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as described in the nisin and subtilin locus as the nis box [112] and the spa box 
respectively [51, 113].  Deletion of the genes encoding the two-component 
system negated the expression of the lanA promoter and the production of 
lantibiotic [51, 54, 114]. Mutation of the LanA peptide, as minimal as a 4 base 
pair deletion, conferred total loss of gene transcription and lantibiotic production 
suggesting that the lantibiotic peptides have dual function of as signaling 
molecule and a growth inhibitory molecule [54, 115, 116].  
While most lantibiotic regulatory proteins perform a transcriptional 
activation role during lantibiotic production, the Enterococcus faecalis cytolysin 
regulator (CylR2) acts in transcriptional repression on both the cylL and cylR 
promoters of the cytolysin operon [117]. The helix-turn-helix (H-T-H) domain of 
CylR2 was shown to bind specifically to the two inverted repeats located between 
the intergenic region of the cylL and cylR promoters to repress transcription of 
the cytolysin genes [55, 118]. The accumulation of an active cytolysin, CylLs”, 
signals the derepression of CylR2, resulting in increased production of cytolysin. 
The CylLs cytolysin is a lantibiotic-family toxin that has activity against both 
prokaryotic and eukaryotic cells. Several Gram-positive bacteria are highly 
sensitive to bactericidal activity of the cytolysin giving E. faecalis a competitive 
advantage in its ecological niche [119]. The cytolysin also contributes to the 
virulence of E. faecalis as it is active against human erythrocytes and innate 
immune cells such as mouse neutrophils and macrophages [120]. 
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The salivaricin locus is a lantibiotic locus found in S. salivarius and S. 
pyogenes with the structural genes of salA (pre-peptide lantibiotic), salM 
(lanthionine modification enzyme), salT (peptidase and transport protein), salXY 
(immunity proteins) and salKR (two-component regulatory system) [59, 121]. The 
promoters controlling this locus in S. salivarius were proposed to be located 
upstream of the salA gene and upstream of the salY gene [59]. However, the 
exact promoter locations have not been reported. The biosynthesis of the sal 
locus in S. salivarius depends on the autoregulation of an extracellular SalA that 
signals the activation of the two component system, SalKR [59]. The mutation of 
a structural gene, either salM, salT, salA or salKR, abrogated the transcription of 
salA in S. salivarius [59]. Exogenous addition of SalA could bypass the lack of 
modification and/or transport proteins and induce salA transcription. However, 
exogenous addition of SalA did not induce salA transcription in a salKR mutant. 
These results suggest the role of SalA as an inducing molecule and the role of 
SalKR in transcriptional activation of sal locus transcription.  
The sal locus in S. pyogenes M14 strain HSC5 has approximately 85% 
homology to the sal locus in S. salivarius. However, the biosynthesis of an active 
salivaricin A is abolished in all S. pyogenes serotypes, except M4, possibly due 
to mutations resulting in early stop codons present in SalM (modifying protein) 
and SalT (transporting protein) [59, 61]. Previous reports demonstrate that salA 
transcription of an S. pyogenes M1 serotype strain can be induced by exogenous 
addition of SalA1 from an S. pyogenes M4 serotype. However, S. pyogenes does 
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not produce a functional salivaricin A and, unlike S. salivarius, does not exhibit 
specific immunity to the salivaricin A lantibiotic [56, 57] suggesting that the genes 
in the sal locus do not function in lantibiotic biosynthesis. Furthermore, the 
complete regulation and expression conditions, along with the functions of the 
proteins encoded by the sal locus genes in S. pyogenes are not known. 
In the previous chapter, we reported a role for the S. pyogenes sal locus in 
virulence, especially the SalKR proteins that are required for resistance to PMN-
mediated killing during host infection. Therefore, it is necessary to understand 
how this locus is regulated and under what conditions these genes are 
expressed, as well as the function of the encoded proteins in order to broaden 
the understanding of S. pyogenes pathogenesis during host-pathogen 
interactions.  
In the present study, we analyzed the transcriptional regulation of the sal 
locus in S. pyogenes and the function of proteins encoded in this locus that are 
involved in this regulation. This is the first study to describe the exact salKR 
promoter location of the sal locus in S. pyogenes. Furthermore, this is the first 
study to demonstrate SalR as a transcriptional repressor of the expression of the 
salKR promoter, together with data, suggesting that SalA may be acting as an 
intracellular signaling molecule. 
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MATERIALS AND METHODS 
 
Bacterial strains, media, and growth conditions. All plasmids were 
maintained in either Escherichia coli DH5α cells or Escherichia coli TOP10 cells 
(Invitrogen) and cultured aerobically in Luria-Bertani medium (BBL) 
supplemented with 25 µg/ml kanamycin, or with 20µg/ml chloramphenicol at 
37°C. The Streptococcus pyogenes M14 serotype, HSC5 strain [82, 83], used in 
this study was cultured anaerobically in THY medium, Todd-Hewitt medium (BBL) 
supplemented with 0.2% yeast extract (BBL), or TP medium, supplemented with 
2% proteose peptone (BBL), and incubated in 15-ml conical tubes at 37°C under 
static conditions. Plasmids in S. pyogenes were maintained with media 
supplemented with 500 µg/ml kanamycin and 3 µg/ml chloramphenicol. S. 
pyogenes cultured on solid medium (THY supplemented with 1.4% agar) was 
incubated in an anaerobic gas chamber with GasPak (BBL) cartridges at 37°C. 
Mid-log phase cultures were grown by diluting overnight cultures of S. pyogenes 
1:50 into fresh THY. When necessary, S. pyogenes mutants were selected on 
THY that contained chloramphenicol (Cam) (3 µg/ml), kanamycin (Kan) (500 
µg/ml), or erythromycin (Erm) (1 µg/ml) as appropriate. 
 
Manipulation of DNA. Chromosomal DNA was purified from S. pyogenes as 
described previously [84]. Plasmid DNA was isolated using Pure Yield Plasmid 
Mini Prep (Promega) and transformed into E. coli and S. pyogenes by 
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electroporation as described previously [84]. Restriction endonucleases, ligases, 
and polymerases were used according to the manufacturers recommendations. 
When required, DNA fragments were purified using a gel extraction kit 
(Fermentas). 
RNA isolation. Ten milliliters of mid-log phase bacterial cultures were 
centrifuged and washed twice with 1xPBS, then the pellet was transferred into 
1.5 ml microfuge tube. The pellet was resuspended in 100 µl TE buffer with 25 
mg/ml lysozyme and 10 mg/ml mutanolysin and incubated at 37°C for 1 hour. 
One milliliter of TRIzol (Invitrogen) was added into the mixture and incubated at 
room temperature for 5 min. Then 200 µl chloroform was added, vortexed and 
incubated for 3 min at room tempertature. The mixture was centrifuged at 13,000 
x g for 15 min at 4°C. The aqueous layer was then transferred into new 
microfuge tube containing 500 µl of isopropanol to precipitate the nucleic acid. 
The samples were then centrifuged at 13,000 x g for 15 min at 4°C. The pellet 
was washed with 70% ethanol and air-dried to evaporatee residual alcohol. The 
nucleic acid pellets were resuspended in 100 µl RNase-free water and 
subsequently treated with DNase and purified with RNeasy MinElute clean up kit 
(Qiagen).  
 
RT-PCR expression analysis of genes in the sal locus. RNA was isolated 
from mid-log phase S. pyogenes cultures grown in THY medium as described 
above. The concentration of RNA was determined using NanoDrop (Thermo 
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Scientific). The RNA was first subjected to PCR amplification to check for 
possible DNA contamination. Initial cDNA synthesis was carried out using AMV 
transcriptase (Fermentas) with 1 µg of RNA sample and a reverse primer 
complementary to the 3’ end of the sal locus, the salZ gene to make a single 
cDNA of the sal locus (salR-hyp-rev, 5’-CGT TCT GGG AGT TGT GAA GC-3’). 
Following incubation at 60°C for 1 hour, the cDNA was purified using the ChIP 
DNA Clean & Concentrator™ (Zymo Research). The cDNA was then used as a 
template for PCR amplification using the primers as described in Table 1. The 
PCR products were visualized on electrophoresis gel stained with SYBR safe 
stain (Invitrogen).  
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Table 1. Primers for RT-PCR. 
PCR Primer name Sequence 
5’ salA-N GAC TAA TGC TAT CGA AGA AGT TTC TG 1 
3’ salA-N-2 GTA TCT AAT ATG TCG TAA TC 
5’sal-seq-5 GAG GAT ATT CGT GAT GAT GC 2 
3’sal-seq-5 CTC ACC ACT GCT ACT ATT TGG 
5’ salT-insert CAC CTT TGG GAG TTA TAT TGG 3 
3’ salK-mid CTT GAG GTG AGA GTA CAA AAG G 
5’ Kan-insert-check GAT GGG AAA CTT CAC ATG GAG 4 
3’ salY-N GAT AAG TCC ATT TGT GAT GAC 
5’salKpro-del3 CGC GGA TCC CAG TTT AGT ATG GTT CCT G 5 
3’salK-del-seq1-salI ACG CGT CGA CAG CTG CTG TAT CAA TAA GCG GTC 
5’ salK pro CGC GGA TCC CAT TGC GGT CAG TGA CAT CC 6 
3’salR-del-seq1-salI ACG CGT CGA CTG CAA ATA GTC TGT GGT CAT C 
5’ salR-del-seq1 GAT ACT TAC CAC CCA ATA G 7 
5’ salR-hyp-rev CGT TCT GGG AGT TGT GAA GC 
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Promoter reporter construct. To measure expression of the salA and salKR 
promoters, a transcriptional fusion was constructed using an alkaline 
phosphatase gene (phoZ) placed downstream of each promoter. The promoter 
regions for salA and salKR were amplified using the primers listed in Table 2.  
The PCR products were gel isolated and digested with BamHI and EcoRI 
(invitrogen). The digested DNA fragments were then ligated using ligase 
(invitrogen) with the pMNN1 plasmid that was also digested with BamHI and 
EcoRI (Figure 13). The ligated products were subjected to butanol precipitation 
and resuspended in 10 µl of nuclease-free water and transformed into E. coli 
DH5α cells. Transformants were selected on LB agar plates containing 25 µg/µl 
Kanamycin and 20 µg/µl Chloramphenicol. The plasmids were propagated in      
E. coli grown in LB medium supplemented with 25 µg/µl Kanamycin and 20 µg/µl 
Chloramphenicol. Each plasmid construct was isolated and transformed into       
S. pyogenes wild type and mutant strains and maintained in THY medium 
containing with 500 µg/µl Kanamycin and 3 µg/µl Chloramphenicol.  Promoter 
sequences were confirmed by sequencing. 
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Table 2. Primers for pMNN1- phoZ reporter constructs. 
Plasmid constructs Primers Sequence 
5' SalA-pro-BamHI CGC GGA TCC GAA TGA TTT TGA GAT ACT TC pMNN-salA pro 
3' SalA-pro-EcoRI CCG GAA TTC CTT CTT CGA TAG CAT TAG TC 
5' SalK-pro-BamHI CGC GGA TCC CAT TGC GGT CAG TGA CAT CC pMNN-salKpro 
3' SalK-pro-EcoRI CCG GAA TTC GCC AGC CAA ATA AAA GCT G 
5-salY-BamHI CGC GGA TCC GAT AGA GGA GAG TAA TAT G pMNN-salKR-pro 
3-salY-EcoRI CCG GAA TTC CAT  ATT ATT TAC TTA ATC G 
5-salKpro-del1 CGC GGA TCC GTT ATC GCT AAT GGG TCA TTG pMNN-salKR-pro del1 
3-salY-EcoRI CCG GAA TTC CAT  ATT ATT TAC TTA ATC G 
5-salKpro-del2 CGC GGA TCC GAC TCC ATC TGC CAT AG pMNN-salKR-pro del2 
3-salY-EcoRI CCG GAA TTC CAT  ATT ATT TAC TTA ATC G 
5-salKpro-del3 CGC GGA TCC CAG TTT AGT ATG GTT CCT G pMNN-salKR-pro del3 
3-salY-EcoRI CCG GAA TTC CAT  ATT ATT TAC TTA ATC G 
5-salKpro-del2 CGC GGA TCC GAC TCC ATC TGC CAT AG pMNN-salKR-pro short 
3-SalY-pro-short-EcoRI CCG GAA TTC GTT TTT CCA AGG CTA ATT TCT G 
5’ salKR pro-del2-EcoRI CCG GAA TTC GAC TCC ATC TGC CAT AG pMNN-salKR-pro short-flip 
3’ salK-pro short BamHI CGC GGA TCC GTT TTT CCA AGG CTA ATT TCT G 
5’salYK-pro del 2A CGC GGA TCC GAG TTA ATG AAA GCT CAA GG pMNN-salKR pro del2A 
3-salY-EcoRI CCG GAA TTC CAT  ATT ATT TAC TTA ATC G 
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Alkaline phosphatase filter lift assay. The bacteria that contained the pMNN1-
sal promoter constructs were grown overnight on agar plates containing the 
appropriate antibiotics, LB medium with 25 µg/µl Kanamycin and 20 µg/µl 
Chloramphenicol and THY medium with 500 µg/µl Kanamycin and 3 µg/µl 
Chloramphenicol. To determine alkaline phosphatase activity of bacteria 
containing promoter constructs on solid medium, a colorimetric filter lift assay 
was used as described previously [122]. The colonies that were alkaline 
phosphatase positive were selected and stored in 40% glycerol at -80°C for later 
confirmation and quantification of alkaline phosphatase activity in the liquid assay 
described below.  
Alkaline phosphatase liquid assay. S. pyogenes strains that contain the 
alkaline phosphatase reporter constructs were grown in THY medium with 500 
µg/ml Kanamycin and 3 µg/ml Chloramphenicol overnight. Subcultures were 
made by transfer into fresh THY medium with the same antibiotics and grown for 
3-4 hours. One milliliter of each log-phase culture was grown with treatment 
alongside an untreated culture for 3 hours at 37°C in the conditions described in 
Table 3 .  
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Table 3. Treatment conditions for sal promoter expression. 
 
Media THY medium and DMEM+10% FBS 
Immune cells or 
immune factors 
human serum or heat-inactivated serum, commercial FBS, 
and charcoal stripped human serum.  
 
After treatment, all cultures were normalized to OD600 of 0.75 in PBS and 50 µl of 
culture was then added, in triplicate, into the wells of a 96-well plate containing 
200 µl of 1-mg/ml p-nitrophenyl phosphate (Sigma) suspended in 1 M Tris (pH 8). 
Following incubation in the dark for 1 hour at room temperature, three optical 
densities (OD405, OD550, and OD600) were measured using a spectrophotometric 
plate reader (VersaMax). Alkaline phosphatase activity was determined using the 
following formula: [OD405 – (1.75 x OD550)]/(volume x time x OD600) x 1,000. Each 
assay was repeated at least three times. 
DIG-labeled sequencing reaction. The fragment for the DIG-labeled 
sequencing template was PCR amplified using primers; 5’-salKpro-del2-CGC 
GGA TCC GAC TCC ATC TGC CAT AG and 5’ phoZ-rev-GTT GCC TTC GCT 
TCA GCA ACC TCT G-3’ with the reporter construct pMNN1-salKR pro-
deletion2-short as template. The fragment was gel purified and the concentration 
was determined using NanoDrop (Thermo Scientific). The sequencing reaction 
was carried out using VentR (exo-) DNA Polymerase (NEB) with 5’ phoZ rev DIG 
labeled primer (DIG-5’-GTT GCC TTC GCT TCA GCA ACC TCT G-3’). The ratio 
of d/ddNTP mix is described in the Table 4 below. Following the PCR reaction, 
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the sequencing products were loaded directly onto the 8% Urea-acrylamide gel 
and ran with constant 45 mA for 3 hours using GIBCO BRL sequencing systems 
(Model S2). The DIG-labeled DNA was transferred onto a nylon membrane using 
capillary transfer method [123]. The labeled products were detected using Anti-
DIG-AP antibody (Roche) and CDP-star (Roche) as a substrate following the 
manufacturer instructions and subsequently exposed to an autoradiograph film. 
Table 4. dNTP and ddNTP ratio for sequencing reaction. 
d/ddATP d/ddGTP d/ddCTP d/ddTTP 
100 mM ddATP 
+ 
0.5 mM dATP 
25 mM ddGTP 
+ 
0.5 mM dGTP 
50 mM ddCTP 
+ 
0.5 mM dCTP 
150 mM ddTTP 
+ 
0.5 mM dTTP 
 
Primer Extension. An overnight culture of S. pyogenes wild type expressing 
pMNN1-salKRpro-deletion2-short was transferred into fresh THY medium 
supplemented with 500 µg/µl Kanamycin and 3 µg/µl Chloramphenicol and grown 
for 4 hours. The cell pellet was collected for RNA isolation (see protocol above). 
Total purified RNA (5 µg) was used in primer extension with 5’-phoZ-rev-DIG 
labeled primer (DIG-5’-GTT GCC TTC GCT TCA GCA ACC TCT G-3’). RNA was 
heated at 90°C for 5 min and immediately cooled on ice. Reverse transcription 
was carried out using AMV reverse transcriptase (Fermentas) and incubated at 
60°C for 1 hour. RNaseA (Invitrogen) was added to the reaction mixture and 
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incubated at 37°C for 1 hour to remove the remaining RNA due to its ability to 
interfere with electrophoresis mobility of labeled cDNA. The primer extension 
products were purified using a ChIP DNA Clean & Concentrator™ (Zymo 
Research) and eluted with 10 µl of nuclease-free water. The corresponding DNA 
sequencing reactions were performed using the same DIG-labeled primer and a 
PCR fragment containing the expected promoter region with Taq DNA 
polymerase sequencing grade (Promega). The extension product and 
sequencing ladder was resolved on an 8M urea-8% polyacrylamide gel. 
Electrophoresis was performed at 1500V, 45 mA for 3 hours. Transfer of labeled-
DNA from the gel onto a Nylon membrane (Magna Charge) was done using the 
capillary transfer method [123]. The labeled products were detected using Anti-
DIG-AP antibody (Roche) and CDP-star (Roche) as a substrate following the 
manufacturer instructions and subsequently exposed to an autoradiograph film. 
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Figure 13. Illustration of the primer extension protocol using a universal primer, DIG 
labeled-5’ phoZ-rev. The black line represents plasmid DNA. RNA was isolated from S. 
pyogenes WT HSC5 strain expressing the reporter plasmid. 5’ DIG labeled-cDNA was 
synthesized using AMV reverse transcriptase.  
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Cloning of salR in to pMAL-c2X. The entire gene of salR was amplified using 
primers	   5’-salR-SmaI (5’-TCC-CCC-GGG-ATG-AAG-ATT-TTA-TTA-ATT-GAT-
GAC-C-3’) and 3’-salR-PstI (5’-AAA-AACT-GCA-GGT-CGT-TTG-ATT-ATC-TGC-
AAC-TCA-G-3’). The PCR products were gel isolated and digested with SmaI 
and PstI. After gel purification, the digested PCR products were ligated into the 
SmaI and PstI site on the pMAL-c2X vector, resulting in pMAL-salR, which 
subsequently was transformed into E. coli Top10 cells (Invitrogen). 
 
SalR protein purification. SalR protein was purified using the pMAL protein 
purification system (NEB) with some modifications. E.coli Top10 cells with pMAL-
salR was grown under shaking conditions at 37°C overnight in LB medium with 
50 ug/ml ampicillin to maintain the plasmid. The overnight culture was then 
transferred into 100 ml of fresh LB media with 50 µg/ml ampicilin and incubated 
under the same growth conditions for 5 hours (OD600 approximately 0.5).  SalR 
production was induced by addition of Isopropyl-b-D-thiogalactoside (IPTG) at 
0.3mM concentration followed by incubation for an additional 2 hours. The cells 
were pelleted by centrifugation at 6500 rpm for 15 min. Cells were resuspended 
in column buffer (20mM Tris-HCl, 200mM NaCl, 1mM EDTA) with Complete mini-
protease inhibitor cocktail (Roche). The cell suspension was then frozen at -20°C 
overnight. The cells were thawed on ice and then lysed by sonication for 15 sec 
intervals for a total of 2 min. The crude cell lysate was collected by centrifugation 
at 9,000 x g for 30 min. The crude extract was diluted 1:10 with column buffer 
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with protease inhibitor added and passed through an amylose column prepared 
as per manufacturer’s recommendation (NEB). The loaded column was then 
washed with 12 volumes of column buffer. The fusion protein was then eluted 
with 1 volume of column buffer supplemented with 10mM maltose and collected 
in 1.5 ml microfuge tubes. The concentration of each elution aliquot was 
measured using the BCA Protein Assay (Thermo Scientific). The highest 
concentration elution aliqouts were combined, desalted and concentrated using 
Amicon spin column with 10 KDa cut off. Collected purified protein was diluted 
with a 1:1 volume of 80% glycerol and stored in aliquots at -70°C.  
 
Electrophoretic Mobility Shift Assay. The electro-mobility shift assay (EMSA) 
was carried out using the DIG gel shift kit 2nd generation (Roche) with minimal 
modification. Six probes were generated by PCR amplification using primers 
described in Table 5. The amplified products encompass DNA sequences within 
the salY region (figure 14). PCR products were gel purified from an 0.8% 
agarose gel using a gel purification kit (Fermentas). Quantification of purified 
PCR fragments were done by using fluorescent-based quantification method 
(Qubit, Invitrogen). Then the fragments were 3’-end labeled with DIG-dUTP using 
terminal transferase as specified in the DIG gel shift kit (Roche). Labeled probes 
were quantified using dot blot methods following the manufacturer’s instructions. 
Binding reactions total volume was 25 µl. Each binding reaction contained 5 µl of 
5X Binding buffer, ~3-6 ng of probe, 0.5 µl of 1mM CaCl2, and 60 ng of Poly dI-C. 
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A variable amount of protein was added to the binding reactions. To confirm 
specific binding, 5X and 10X excess non-labeled specific probe was added. The 
binding reactions were incubated at room temperature for 45 min then 5 µl of 
loading buffer (kit) was added. Samples were mixed gently then loaded onto 8% 
TBE non-denaturing polyacrylamide gel. Initial voltage was set to 300V for 10 
min to allow protein/probes and protein-probe complex to enter the gel. The gels 
were then run at 150V for 30-45 min. The reactions from the gel were 
subsequently transferred onto a positively charged nylon membrane (Magna 
charge) using a semi-dry electrotransfer apparatus (Bio-Rad).  Probe mobility 
was then visualized with chemiluminescent detection as described in the DIG gel 
shift protocol. Membranes were exposed to X-ray film (Denville) and developed 
in an autoprocessor. 





Figure 14. The location of PCR amplification products for DIG-labeled probes for EMSA. 
The yellow bars represent PCR products amplified using the primer sets described in the 
table 5 below. 
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Table 5. Primers for PCR amplification of DIG labeled probes 
Probe 
number Primers Sequence 
5-salY-BamHI CGC GGA TCC GAT AGA GGA GAG TAA TAT G 
P1 3-salY pro#5 GAC TCC AAG CTC TTG ACT ACG 
5-salY-N CGT AGT CAA GAG CTT GGA GTC 
P2 3-salY-N GAT AAG TCC ATT TGT GAT GAC 
5-salYK-pro del1A CGC GGA TCC CAG CTA ATG AGA TTA TAG AGT C 
P3 
3-salY pro#4 GCA TAG AGC ATT ACC ATC 
5-salKpro-del2 CGC GGA TCC GAC TCC ATC TGC CAT AG 
P4 3-SalY-pro-short-EcoRI CCG GAA TTC GTT TTT CCA AGG CTA ATT TCT G 
5-salKpro-del3 CGC GGA TCC CAG TTT AGT ATG GTT CCT G 
P5 3-salY pro#2 CAT TAT GAT ATT GCC TGC TAC C 
5-salK-pro-BamH1#2 CGC GGA TCC CCT GTA TTC ATT GGG ATT G 
P6 3-salY-EcoRI CCG GAA TTC CAT  ATT ATT TAC TTA ATC G 
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Adherence and Internalization assay with macrophage cells. RAW 264.7 
murine macrophage cells were seeded at 1 × 106 cells/ml per well into a 24-well 
plate and allowed to adhere overnight in a 5% CO2 incubator at 37°C. The 
following day, cells were washed three times with PBS and incubated with log-
phase S. pyogenes HSC5 in DMEM supplemented wit 10% FBS at 1 × 106 
CFU/ml per well, a multiplicity of infection (MOI) of 1. To allow close contact of 
bacterial cells to macrophages, the 24-well plate was centrifuged briefly for 5 min 
at 1,000 rpm with a soft start and stop at room temperature. The plate was then 
incubated for 1 hour at 37°C in a 5% CO2 incubator. Following the incubation, 
each well was washed 5 times with PBS to remove non-adherent cells. One set 
of the infected macrophages was then lysed, by the addition of 1 ml of sterile 
double-distilled water, serial diluted in PBS and plated to determine the number 
of adherent and internalized bacterial cells. The other set was incubated for an 
additional hour in fresh DMEM plus 10% FBS with 100 µg/ml gentamicin 
(Invitrogen) added to eliminate extracellular bacteria. Following the gentamicin 
treatment, the plate was washed three times with PBS. The 0 hour-time point 
aliquot was then collected and plated as described above for number of 
internalized bacteria cells at the 0 time point. Fresh DMEM plus 10% FBS 
containing no antibiotic was added to each remaining well. At the 24-hour time 
point, aliquots were taken from the supernatants and cells were lysed and plated 
for enumeration of viable bacterial cells after 24 hours in macrophages. 
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Construction of the salA overexpression (salA o/x) plasmid. The full length 
salA gene including the ribosomal binding site was PCR amplified using primers 
5’-salA RBS BamHI-CGC GGA TCC CTG ATA GAA AGG AGA ATG AG and 3’-
SalA stop PstI-AAA ACT GCA GTT AAC AAC AAA CGA ATA CTG using S. 
pyogenes wild type (HSC5) chromosomal DNA as a template. The PCR product 
was gel-purified from an 0.8% agarose gel with a gel purification kit (Fermentas). 
Following the restriction digest with BamHI and PstI, the PCR fragment was 
purified using a PCR clean-up kit (Fermentas) and cloned downstream of the 
Streptococcal rofA promoter on the pLZ12 vector [124, 125]. The expression 
plasmid was transformed and propagated in E. coli TOP10 cells (Invitrogen). The 
correct construct was confirmed using colony PCR with the primers mentioned 
above and sent for sequencing. The plasmid was isolated using a plasmid midi 
prep kit (QIAGEN) and transformed into S. pyogenes wild type conferring a salA 
overexpression strain. 
 
Determining whether the effect of SalA is intercellular or extracellular. 
Overnight cultures in THY medium of wild type, SalA-IFD (in-frame deletion) and 
salAo/x (WT expressing pLZ12-rofA-salA), were sub-cultured into fresh THY 
medium containing E-64 cysteine protease inhibitor. After the cultures were 
incubated at 37°C for 4 hours, they were centrifuged and bacterial cells filtered 
out using a 0.20-micron syringe filter (BD). The supernatant (spent media) was 
collected from the subcultures and fresh E-64 was added to the spent media to 
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inhibit protease activity, especially SpeB. S. pyogenes wild type and salA-IFD 
strains harboring pMNN1-salKRpro-phoZ were also subcultured into fresh THY 
medium and incubated 37°C for 4 hours. The cell pellets were collected by 
centrifugation at 6500 rpm for 10 min and the supernatant discarded. The cell 
pellets were then incubated with the spent media described above for another 3 
hours at 37°C. After treatment, all cultures were normalized to OD600 of 0.75 and 
analyzed by the liquid alkaline phosphatase assay described above.  
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RESULTS 
 
Analysis of sal locus gene expression. To determine whether genes in the sal 
operon of S. pyogenes M14 HSC5 strain are co-transcribed, we performed RT-
PCR on mRNA isolated from the wild type strain during mid-log phase growth in 
THY media.  A single primer that annealed to a sequence downstream of the sal 
locus in the reverse orientation was used to make a cDNA of the sal operon 
transcript.   Fragments were amplified by PCR using the cDNA made from the sal 
transcript and primer pairs (see table 1) that overlap the 3’ and 5’ region of 
adjacent genes to confirm co-transcription.  As shown in figure 15, we detected 
amplification products representative of a single transcript for all the genes in the 
sal locus including the newly identified hypothetical protein encoded by the salZ 
gene at the 3’ end of the sal operon.  
 






Figure 15. RT-PCR analysis of genes in the sal locus expressed in WT S. pyogenes.     
A) Illustration of the over lapping primer pairs 1-6 and their location on the sal locus.      
B) RT-PCR products from primers 1, 5 and 7, showing negative control using RNA 
sample with no RT in lane 1, cDNA from duplicated RNA sample i and ii. in lanes 2 and 
3 and positive control with same primers and DNA. C) RT-PCR products using sample i 
as a template with primers 2, 3, 4 and 6. The negative control was done with no RT 
control.  
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Promoter identification. The promoter constructs for the putative salA and salK 
promoter regions were determined by the common organization of genes and 
promoters in lantibiotic loci [47]. The regions upstream of salA and upstream of 
salK were amplified by PCR as depicted in figure 16A.  These regions were 
cloned individually upstream of the alkaline phosphatase reporter gene, phoZ, in 
plasmid pMNN1 and then transformed into the wild type S. pyogenes strain. Mid-
log phase cultures of the wild type strain expressing pMNN-salApro and pMNN-
salKpro were tested for alkaline phosphatase activity. The strain expressing the 
salA promoter plasmid had 2470±128.84 units of alkaline phosphatase activity 
(figure 16B), whereas there was no alkaline phosphatase activity detected from 
the wild type strain expressing the salK promoter. This indicates that there is a 
promoter sequence within salA promoter construct region, while suggesting the 
absence of a promoter sequence within salK construct region. 
To identify the region that contains a promoter for regulation of salKR 
expression, ~2000 bp upstream of the salK gene, encompassing the entire open 
reading frame of salY, was cloned into the pMNN1-reporter plasmid. This 
promoter construct was called salKR pro. Alkaline phosphatase activity of 
985±177.60 units (figure 16B) was detected in the wild type strain expressing 
pMNN1-salKRpro indicating that an additional promoter of the downstream 
genes of sal locus is located within salY gene. Therefore two promoters were 
identified in the sal locus of S. pyogenes M14 HSC5 strain, one located upstream 
of the salA gene and the other located within the salY gene.  







Figure 16. sal locus promoter identification. A) Illustration of the genetic map of the 
possible promoter locations suggested by the common organization of lantibiotic loci. 
The promoter regions were amplified using PCR (primers described in table 2 ).             
B) Alkaline phosphatase activity of WT S. pyogenes strain HSC5 harboring pMNN1-sal-
promoter. Error bars reflect the standard errors. 
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Analysis of the salKR promoter. To narrow down the sequences required for 
expression of the salKR promoter, truncated forms of the salKR promoter region 
from plasmid pMNN-salKR with deletions from the 5’ end were cloned into the 
same reporter plasmid as represented in figure 17. Truncation of 187 bp from the 
5’ end (deletion 1) resulted in an increased expression of salKR promoter activity. 
Further truncation of another 806 bp from 5’ end (deletion 2) resulted in double 
the alkaline phosphatase activity compared to the full-lengh salKR promoter 
region. The increased promoter activity after deletion of the 5’ sequences is 
indicative of a possible repression site(s). However, an additional deletion of 393 
bp demonstrated a total loss of promoter activity, suggesting that promoter 
elements are contained within the 393 bp region. 
A deletion from the 3’ end of the deletion 2 construct, leaving only the 393 
bp region also showed increased expression compared to the deletion 2  
construct, suggesting that another possible repression site or alternatively, a 
terminator site is located downstream of the promoter region. To confirm that this 
region contained the -10 and -35 promoter elements, the 393 bp was cloned in 
the reverse direction (3’ to 5’) into the reporter plasmid, which resulted in no 
activity. Therefore the sequences required for the salKR promoter lie within the 
393 bp region from 6888-7181 of the salY gene. (figure 17).  
 




Figure 17. Analysis of the salKR promoter. Alkaline phosphatase activities were 
produced by S. pyogenes WT strain HSC5 expressing various truncations of salKR 
promoter reporter plasmid. The PhoZ activity was measured using a colorimetric assay 
with standard errors illustrated as error bars. The red boxes represent the DNA regions 
with possible repression sites. The green boxes represent the possible promoter region. 
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Mapping of the salKR transcription start sites. To confirm the read-through 
transcript provided by the salA promoter, RT-PCR was also performed with an 
RNA sample isolated from a salY in-frame deletion strain, which would result in a 
deletion of the salKR promoter. Results revealed that the salK transcript was still 
detected using primers for the salK gene (figure 18B) in the absence of the salKR 
promoter, indicating a read-through transcript from the salA promoter (figure 
18A).  
 The exact location of salKR promoter elements was identified using primer 
extension. The protocol utilized a DIG-labeled universal primer that annealed to 
the reverse of the 5’end of phoZ gene as described in the figure 13. This protocol 
is designed to eliminate the interference of the long mRNA that is transcribed 
from  the salA promoter. 
The -10 and -35 promoter region was determined from identification of the 
transcription start site (+1 site) of the salKR transcript. A well conserved 
consensus -10 region (TATAAT) was identified as well as a degenerate -35 
(TgGgCA) site (figure 19). 
 






Figure 18. A) Illustration of the read-through transcript provided by the salA promoter.   
B) RT-PCR analysis of the WT strain and the salY-deletion strain RNA using one step-
RT-PCR i(nvitrogen) with salK primers. Lane1. negative control; lane 2, WT RNA and 
lane 3, salY deletion strain RNA.  
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 Primer Extension 
 
 
Figure 19. Identification of the 5’ end of the salKR transcript that was transcribed from 
the salKR promoter expressed off the plasmid, pMNN1-salKR-deletion 2 short. The 
primer extension analysis was used to identify a transcriptional start site of salKR 
transcripts. The primer extension product is shown on the far right lane (P*). The 
nucleotide start site (red letter G) was compared to the sequencing ladder. The promoter 
region was identified from the transcription start site, -10 consensus region shown in red 
and a putative -35 shown in green.  
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SalR regulates salKR promoter expression. Based on homology to other two-
component regulators, the SalK and SalR proteins comprise a putative two-
component regulatory system. The putative regulator, SalR, has a conserved 
DNA binding domain that would allow it to bind directly to DNA resulting in 
regulation of gene expression. Most lantibiotic regulators control expression of 
their own promoters [52, 54, 115]. Therefore, to determine whether SalR has an 
effect on the salA and/or the salKR promoter expression, the reporter plasmid 
containing either the salA or salKR promoter was transformed into a strain 
containing a deletion of the salKR genes (ΔsalKR, construct details in methods). 
We compared salA and salKR promoter activity from the WT and the ΔsalKR 
deletion strain over time. Results showed that salA promoter expression was not 
affected by the absence of SalKR. In contrast, salKR promoter activity in the 
ΔsalKR strain was two times higher than in the wild type strain that expressed 
SalKR (figure 20). These results suggest that the SalR protein can act as a 
regulator to repress the expression of its own promoter.  
 




Figure 20. Alkaline phosphatase activity. The comparison of alkaline phosphatase 
activities produced by the WT and the ΔsalKR strains expressing the salA or the salKR 
promoter reporter plasmid. The alkaline phosphatase activities were measured using a 
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SalR binds specifically to regions upstream and downstream of salKR 
promoter.  To examine binding of the SalR protein to the salKR promoter region, 
we cloned the salR gene into the pMAL fusion vector and then expressed the 
pMAL-salR fusion in E. coli (Top10).  The SalR protein was transcribed and 
translated as an MBP fusion protein, which was subsequently purified using an 
amylose column. Purified MBP-SalR was tested for the ability to bind to the 
salKR promoter region and areas surrounding the promoter region (figure 21A) 
using an Electrophoretic Mobility Shift Assay (EMSA). The probes for DNA 
binding assays were amplified using PCR (see methods) and were then 3’ end-
labeled with DIG and used as probes in the EMSA assays. Results demonstrated 
that the SalR protein binds specifically to probe 3, the region upstream of the 
salKR promoter, but did not bind directly to the promoter region, probe 4 (figure 
21B). In addition to the upstream region, SalR also bound probes 5 and 6, which 
are regions downstream of the salKR promoter. We could compete for protein 
binding with excess un-labeled probe resulting in a shift in the probe to the 
unbound position (figure 21B). Moreover, the SalR protein showed differential 
binding affinity by comparing binding of the upstream region to the downstream 
region of the salKR promoter using an EMSA competition assay (figure 22). 
Probe number 3 showed the highest affinity binding to the SalR protein as it can 
completely compete with probe number 5 or 6. While probe 5 or 6 cannot fully 
compete probe 3 even when the un-labeled probe was added at ten times the 
concentration of the labeled probe.  
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Together, the data suggest that SalR regulates the expression of the 
salKR promoter by binding directly to sequences both upstream and downstream 
of the promoter.  
	   89	  
Electrophoretic Mobility Shift Assay  
 
 
Figure 21. SalR binds to sequences upstream and downstream of the salKR promoter. 
A) The genetic map of the salY gene containing the salKR promoter depicted in blue, 
and the DIG labeled probes tested in the gel shift assay shown in yellow. B)  
Electrophoretic mobility shift assay showing binding of the SalR protein to the DIG-
labeled DNA probe. Every lane contained 3-6 ng of probes. Lane 1 of each gel, probe 
alone; Lane 2 and 3, probe with an increasing amount of MBP-SalR protein, 25 ng- 50ng 
respectively.  Lane 4 and 5, probe with 50 ng of MBP-SalR protein plus 5 fold and 10 
fold of excess specific unlabelled probes. 




Figure 22. Affinity binding of MBP-SalR to the DIG-labeled DNA probes. The competitive 
assay was done using probes 3 and 6. Lane 1 contains 5-6 ng of probe only; lane 2-4, 
probe with increasing amount of MBP-SalR protein, 6.5 ng, 13 ng and 26 ng 
respectively; lane 5-10, probe with 26 ng of MBP-SalR and 10 fold excess amount of 
unlabeled competitor DNA.   
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The salA-IFD strain has a phenotype with enhanced adherence to 
macrophage cells. On a THY agar plate, the salA-IFD strain has a different 
colony morphology compared to the WT strain. The salA-IFD colonies appear 
larger and more mucoid. This suggested the possibility of an increased 
expression of capsule in the salA-IFD strain.  However, RT-PCR analysis of hasA 
gene expression, which in S. pyogenes controls capsule expression, revealed no 
difference from the wild type hasA expression (data not shown).  Moreover, 
buoyant density Percoll gradients demonstrated that the highly mucoid colony 
phenotype was not due to an increased production of capsule (data not shown).  
 Analysis of adherence and internalization of the salA-IFD strain using a 
macrophage infection assay demonstrated that the mutant strain bound and was 
internalized at a rate that was approximately two fold higher than that of WT 
(figure 23). This phenotype could be complemented with the addition of a 
plasmid that constitutively expressed the salA gene from the streptococcal rofA 
promoter. Interestingly, the same plasmid expressed in the S. pyogenes wild type 
strain (salA o/x) creating an overexpression of salA (plasmid and chromosomal 
salA expression), resulted in an adherence and internalization rate that was 
almost two fold less than the wild type strain alone (figure 23).  




Figure 23. Adherence and internalization in of the bacteria in macrophage cells. 
Bacterial adherence and internalization at the initial interaction with murine macrophage 
cell line. The percent of bacteria recovered from the macrophage cells was calculated 
relative to the initial inoculum. The blue bars represent the percent of adhered and 
internalized bacteria and the red bars represent the percent of internalized bacteria. The 
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SalA affects the salKR promoter expression. Most lantibiotic locus promoters 
are autoregulated and expression is induced when sensing the presence of the 
cognate lantibiotic peptide [47, 54]. While S. pyogenes M14 HSC5 strain does 
not produce detectable SalA lantibiotic activity, we did observe salA transcripts 
by RT-PCR. To investigate if SalA plays a role in expression of the salA promoter 
and the downstream salKR promoter, the salA and salKR promoter reporter 
plasmids were transformed separately into the wild type and a salA in-frame 
deletion (IFD) strain. Expression analysis revealed that the salA promoter was 
not affected by the absence of the SalA peptide, whereas salKR promoter activity 
in the salA-IFD strain was significantly (p value < 0.005) increased (figure 24) 
suggesting that SalA plays a role in salKR promoter repression.  




Figure 24. Alkaline phosphatase activity. Comparison of the alkaline phosphatase 
activities produced by the WT and the salA-IFD strains expressing pMNN1 salA or salKR 
promoter plasmid.  
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SalA does not act extracellularly to affect salKR promoter expression. While 
the SalA peptide from S. salivarius is known to be secreted extracellularly to act 
as a signal for the histidine kinase in addition to its function as a lantibiotic, the 
cellular location of the S. pyogenes SalA peptide is not known.  To determine if 
the S. pyogenes SalA peptide acts intracellularly or extracellularly to affect salKR 
promoter expression an alkaline phosphatase assay was performed on the wild 
type and the salA-IFD strains that contain the salKR reporter plasmid.  If SalA 
acts extracellularly, then the peptide would be secreted and found in the 
supernatant of cultures.  As the salA promoter was found to be expressed at the 
highest level in late log phase growth (Figure 25) spent media was taken from 
cultures of the wild type, salA-IFD and salAo/x (a WT that constitutively 
expressed salA from a plasmid) strains grown to late log phase. The spent media 
was then used to treat wild type and salA-IFD cultures expressing the salKR 
reporter plasmid for 3 hours, after which an alkaline phosphatase assay was 
performed to measure promoter activity.  All spent media cultures were treated 
with E64, a cysteine protease inhibitor, to prevent degradation of the secreted 
SalA peptide by SpeB.  The results revealed that no changes in promoter activity 
were detected in either the wild type or the salA-IFD strains treated with spent 
media compared to untreated strains (data not shown), suggesting that the 
promoter expression difference observed between the strains may be due to the 
intracellular action of SalA.   
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The analyses of salKR promoter expression in the mutants revealed that 
the full-length promoter expressed higher in both salA-IFD and ΔsalKR mutants 
compared to that of WT. However, the shortest promoter construct, pMNN1-
salKR pro-deletion 2 short, with minimal or non-repression sites, the promoter 
expression were highly expressed in all strains (figure 25). 
 




Figure 25. Alkaline phosphatase activities measured in the WT, the salKR and the salA-
IFD strains expressing various truncations of the salKR promoter reporter plasmid. The 
green regions represent the salKR promoter location. The values in the table show 
alkaline phosphatase activity units with standard errors.  
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Both the salA and the salKR promoters respond to human serum. Genes in 
the sal locus are important for full virulence of the S. pyogenes strain HSC5 [61]. 
To examine if the two promoters identified were affected by host factors, we 
tested the promoter expression of salA pro and salKR pro (full length-contains all 
the regulation sites) in the wild type strain, in the presence of human serum 
compared to fetal bovine serum. A significant (P value < 0.05) increase in 
expression of both the salA and salKR promoters was detected when exposed to 
human serum (figure 26).  In an effort to determine what factors in the human 
serum were responsible for the increase in promoter activity, the serum was heat 
inactivated, which destroys complement factors found in the serum, or charcoal-
stripped, which results in removal of hormones.  Even under these conditions 
both promoters still expressed higher activity than with THY medium alone or 
with fetal bovine serum, suggesting that factors in the serum other than 
complement or hormones are responsible for the increased promoter activity. 
 




Figure 26. The sal promoter expression.  Alkaline phosphatase activities produced by 
WT S. pyogenes expressing pMNN1-salApro or pMNN1-salKRpro-full length after 3 
hours of treatment with several conditions; ThyB medium, fetal bovine serum (FBS), 


































	   100	  
DISCUSSION 
 
This study demonstrated that there are two promoters in the sal locus of 
S. pyogenes, one located upstream of the salA gene, controlling the expression 
of the entire locus and another promoter located within the salY gene, controlling 
the expression of the downstream salKRZ genes.  This organization is similar to 
that found in other lantibiotic loci [59, 112, 113, 126, 127]. As shown by RT-PCR 
the salA promoter provides a read-through transcript, demonstrating that the 
salAMTXYKRZ genes are co-transcribed as a single transcript. The presence of 
the internal promoter suggests that the expression of salKRZ could be regulated 
independently from the salA promoter under different physiological conditions. 
These two promoters were found to have different expression profiles during 
growth. The salA promoter activity was detected strongly in early mid-log phase 
while the salKR promoter had much lower activity overall compared to the salA 
promoter with the highest expression detected in late-log phase indicating 
differential regulation for the salKR promoter.  
Analysis of promoter activity in truncated versions of the salKR promoter 
suggested possible repression sites located both upstream and downstream of 
the promoter region. Deletion of both putative repression sites resulted in a 6-fold 
increase in salKR promoter expression. These results suggest that the salKR 
promoter requires tight regulation, indicating the importance of regulated 
expression of the downstream genes, salKR, encoding the two-component 
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signaling system. Previous reports demonstrate that the SalKR two-component 
system is required for full virulence of pathogenic bacteria like S. suis [128] and 
S. pyogenes [61].  
As a transcriptional regulator, SalR represses its own salKR promoter by 
binding directly to the identified repression sites of the promoter. This feedback 
loop repression suggests that this promoter is only expressed transiently under 
certain conditions. Our finding correlates with the microarray data from               
S. pyogenes growth in human blood reporting that the salR transcript is 
increased 50 fold after only 30 min of exposure to blood, but reduced to 1.28 fold 
after 60 min and then upregulated again to 30 fold after 90 min of exposure [99]. 
The complex regulation of the salKR promoter is to ensure that the downstream 
genes, salKRZ, are only expressed at the appropriate time. Further investigation 
is required to identify possible global regulatory functions of SalR. We propose 
that SalR may also regulate genes other than those in sal operon. This 
hypothesis is supported by the microarray data from S. suis showing several 
genes encoding transporters and recombination proteins to be downregulated in 
the absence of salKR [128].  
In most two component regulatory systems, the response regulator is 
required to be phosphorylated by the cognate histidine kinase to be active. The in 
vitro binding assays demonstrating the binding of SalR to regions surrounding 
the promoter occurred in the absence of SalR phosphorylation.  A similar result 
was reported for the recently identified BovR response regulator encoded in the 
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bovicin lantibiotic locus of S. bovis that can bind to the bovA promoter region in 
the absence of phosphorylation [114]. Non-phosphorylated SpaR of the subtilin 
lantibiotic locus of B. subtilis binds to the spaA and spaF promoters at a 
conserved spa-box, a repeated pentanucleotide sequence (A/T)TGAT separated 
by six nucleotides [51]. Therefore, further investigation of the SalR DNA binding 
sequence could allow us to determine a consensus binding sequence, possibly 
leading to identification of other genes that are also regulated by SalR.  
Unlike other lantibiotic operons where deletion of the two component 
regulatory system, lanKR, results in abrogated expression of the lanA promoter 
and loss of lantibiotic biosynthesis [52, 54, 59, 112, 114], the deletion of salKR in 
S. pyogenes HSC5 did not affect the activity of the salA promoter. Previous 
reports demonstrate that none of the S. pyogenes serotypes, except M4, produce 
an active Salivaricin A lantibiotic even though salA transcript was present [57, 59, 
129], suggesting that the peptide is produced but not modified to the active 
lantibiotic.  Our data suggest a role for the SalA peptide in S. pyogenes.  As 
demonstrated above, SalR represses its own promoter, possibly in a feedback 
loop fashion, and generally, feedback loop repression, such as in the Lac operon, 
involves a cofactor or a co-repressor [130]. In our study, we hypothesize that the 
SalA peptide may play a role in co-repressing the salKR promoter as suggested 
by the results from the promoter expression analysis when in the absence of 
salA, salKR promoter expression was increased. This effect appeared to be 
additive as a double deletion strain of salA and salKR showed the highest 
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promoter expression (data not shown). For this to occur, localization of SalA 
should be intracellular as opposed to extracellular. However, we have not yet 
been able to detect SalA as either intracellular or extracellular using an antibody 
against a synthesized SalA peptide (data not shown). This suggests that SalA 
may be modified by S. pyogenes and therefore cannot be recognized by the 
antibody.  
Mapping of the transcription start site of the salKR promoter revealed a 
well-conserved -10 region (TATAAT) with a putative (TgGgCA) -35 region. The 
promoter also contained the consensus sequence for an extended -10 promoter 
region (TNTGNTATAAT) with one underlined nucleotide mismatch to that in S. 
mutans but consensus to that in S. pneumoniae [131, 132]. The extended -10 
promoter region is also found in front of other lantibiotic promoters, including the 
mutR promoter of the S. mutans mutacin II operon and the nisR promoter from 
the nisin locus in Lactococcus lactis [112, 133]. Interestingly, while the nisR 
promoter is constitutively expressed, the mutR promoter is controlled by an 
upstream repeat sequence that is a proposed consensus binding site for a LytR 
family regulatory protein [132]. The complex transcriptional regulation of 
lantibiotic two-component systems is also in evidence in the subtilin locus of B. 
subtilis. In this locus, the spaKR promoter is regulated by an alternative sigma 
factor H, which is in turn inhibited by a transition state regulator, ArbB [52]. 
Therefore, the regulation of lanKR promoter regions appears to be specific for 
each operon.  Notably, the regulation of the salKR promoter is not affected by the 
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S. pyogenes global regulators CovR [95], Mga [134] or Rgg [38] as salKR 
promoter expression did not change when analyzed in strains carrying mutations 
in these regulators under the conditions tested (data not shown). However, this 
does not rule out a role for these regulators in vivo. 
Both the salA and the salKR promoters show increased promoter activity 
when grown in media containing human serum. The signaling molecule(s) 
responsible for the increased expression are heat-stable, non-hormonal 
molecules that are unique to human serum, as the same result was not observed 
with fetal bovine serum. This response suggests that the sal locus in S. 
pyogenes is involved in sensing and responding to host-pathogen interactions in 
vivo, which is supported by the increased expression of the sal locus genes 
observed during an acute and chronic macaque pharyngitis infection model [96] 
as well as during growth in human blood [99].  
In conclusion, this study demonstrated that even in the absence of 
production of a functional lantibiotic, the sal locus genes of S. pyogenes are 
expressed and differentially regulated.  The complex regulation observed for the 
salKR promoter suggests the importance of the appropriate expression of the 
downstream genes, salKRZ. Several bacteriocin-like loci found in bacterial 
pathogens have been implicated in virulence, such as the sag operon in S. 
pyogenes [20], the salKR locus in S. suis [128], the Enterococcal cytolysin in E. 
faecalis [55, 135] and the Bsa bacteriocin locus in S. aureus [136]. Therefore, 
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further study of the role of the S. pyogenes sal locus in vivo is necessary to fully 
understand pathogenesis during host-pathogen interactions. 
 





In order for S. pyogenes to adapt, persist and disseminate to various sites 
of infection within the host requires an ability to regulate multiple virulence genes 
in response to changes of environmental signals. The role of two-component 
regulatory systems in responding to environmental stimuli to affect overall 
bacterial cell modification by global differential gene expression is well 
established. One of the mutants identified in a transposon mutagenesis screen 
[61] has a transposon inserted in the salK gene, encoding a sensor kinase of a 
two-component regulatory system. The salK transposon mutant (salKΩ) is highly 
attenuated in the zebrafish infection model. The salK gene is located within the 
salivaricin locus (sal locus), a lantibiotic locus encoding genes that regulate and 
function in lantibiotic production [59]. While the putative functions of the sal locus 
gene products have homology to lantibiotic producing proteins, S. pyogenes 
does not produce an active salivaricin A nor is it immune to salivaricin A 
produced by S. salivarius [59, 121]. Interestingly, even without the lantibiotic-
producing functions, this locus is highly conserved among different S. pyogenes 
serotypes.  Furthermore, the genes in the sal locus of S. pyogenes were highly 
expressed during an acute or persistent form of pharyngitis [96] as well as during 
exposure to host factors such as polymorphonuclear leukocytes (PMNs) [45] and 
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human blood [99]. This data, together with the observed attenuation of the salKΩ 
mutant in zebrafish, is consistent with a role for SalK in the virulence of S. 
pyogenes.  
Two component systems generally are composed of a sensor kinase that 
interacts with a cognate response regulator.  This is also true in the S. pyogenes 
salivaricin locus with the SalK sensor signaling kinase and the cognate regulatory 
protein, SalR. Previous to our STM screen, there are no reports of the S. 
pyogenes SalKR playing a role in virulence.  Only one previous report showed 
that the SalKR homologs in S. suis play a role in resistance to PMN-mediated 
killing during a piglet infection [128]. Interestingly, S. suis carries only the salKR 
genes with no other homologous genes from the sal locus suggesting that it 
acquired the salKR genes horizontally and subsequently evolved a function in 
virulence. An in-frame deletion of the salKR genes in S. pyogenes conferred a 
similar attenuation as that observed in the salKΩ mutant. Therefore, the original 
attenuation was not due to a polar mutation on downstream genes. The data 
presented here are the first to report a virulence role for SalKR in S. pyogenes. 
An in vivo infection in the zebrafish model resulted in a similar necrotic 
lesion developing at the site of injection between the wild type and the ΔsalKR 
strain.  The two strains produced the same level of proteolytic enzyme, SpeB, 
which is responsible for the necrotic lesion. However, the mutant demonstrated 
an attenuated ability to disseminate to the spleen. Further investigations revealed 
that the attenuation of the ΔsalKR mutant strain was due to the inability to survive 
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in human whole blood because of its susceptibility to neutrophil killing, 
specifically to cell lysis by lysozyme. The major lysozyme resistance mechanism 
of some Gram-positive pathogens is bacterial cell wall modification. The 
sensitivity to lysozyme of the salKR mutant suggested that its cell wall 
modification process is different from the wild type strain. The cytochrome C 
binding assay showed that the overall net charge of the cell wall of the wild type 
and the salKR mutant strain were different, confirming the dissimilarity of their 
cell walls. S. pyogenes possesses the cell wall modification genes, pgdA, tagO, 
oatA and dltA, that contribute to lysozyme resistance in other Gram-positive 
bacterial pathogens [79, 103, 104, 106, 137].  Genes in the dlt operon of S. 
pyogenes, involved in D-alanylation, are concomitantly expressed with the genes 
of a two component system, ihk/irr, during phagocytosis by neutrophils [44].  The 
D-alanylation process was shown to increase S. pyogenes resistance to the 
neutrophil-derived cationic antimicrobial peptides, defensins, LL-37, CathepsinG 
and lysozyme [77, 78, 138]. However, the Ihk/Irr system has been proven to 
particularly respond to reactive oxygen species (ROS) produced by activated 
neutrophils.  ihk/irr expression was induced by exposure to H2O2. The irr mutant 
exhibited sensitivity to ROS as well as cationic-antimicrobial peptides [44]. In 
addition, the genes that encode proteins involved in cell wall formation, which are 
regulated by the Ihk/Irr system may be directed towards resistance to ROS, 
which could also have an effect on the resistance to antimicrobial peptides. 
Conversely, the salKR mutant was not more sensitive to H2O2 and cationic-
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antimicrobial peptides than the wild type strain. As a regulatory protein proven to 
specifically bind to DNA, SalR is most likely playing a role in differential gene 
expression that would result in cell wall modification directly towards a lysozyme 
resistance mechanism. Further analysis is required to determine the exact 
mechanisms regulated by SalKR. As dissemination to different sites of infection 
is a crucial step for systemic infection by S. pyogenes, the salKR mutant lacks 
the ability to survive in the presence of neutrophils, which results in a loss in the 
ability to disseminate and cause invasive disease.   
Tight regulation of virulence gene expression is essential for a successful 
systemic infection when bacteria encounter the harsh environment created by the 
host immune response. In addition, an adaptive response triggered by specific 
host environments allows the systemic pathogen to be protected from 
subsequent insults.  One important finding from this study was the onset of an 
intracellular adaptation process initiated by S. pyogenes while in macrophages, 
which allowed an increased resistance to subsequent in vitro neutrophil killing. 
This adaptation was shown to be SalKR-dependent. Of note in these assays was 
the observation that the percent survival of bacteria in neutrophils from the post-
DMEM treatment was relatively lower than the previously described neutrophil 
experiments where cultures were first grown in THY media. This difference was 
possibly due to the growth phase of the inoculum as well as the nutritive 
environment. While the original neutrophil experiment was done with mid-log 
phase cultures grown in a rich medium, post-macrophage and post-DMEM 
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cultures required late stationary phase growth, ~20 hour after infection, in order 
to have the same inoculum. These results demonstrated that late stationary 
phase cultures do not survive neutrophil killing as well unless the culture has 
previously been passaged through macrophages. This may be due to several 
virulence factors having growth phase-dependent expression [139-141]. The mid-
log phase culture of S. pyogenes has the highest expression of Mga, a ‘stand 
alone’ regulator, which was shown to regulate gene products related to adhesion 
and internalization. At this stage, the bacteria produce a high level of M-protein, 
capsule and C5a peptidase. Expression of Mga is shut off once the cell enters 
stationary phase and other growth phase regulators take over the control of gene 
expression, resulting in differential virulence factor production [140, 141]. Multiple 
S. pyogenes two-component regulatory systems, CovRS, Ihk/Irr and FasBCAX, 
are expressed during stationary phase of growth [141]. The expression of the 
salKR promoter tested in this study is not under the influence of either Mga or 
CovR, although the expression profile of the salKR promoter showed the highest 
expression at late log phase, going into stationary phase. The survival difference 
observed in the neutrophil assays is possibly due to differences in overall 
virulence gene production based on a particular growth phase.  Resistance to the 
host immune response is not dependent on one particular virulence factor but the 
overall differential gene expression resulting in bacterial adaptation [141]. 
Gene regulation in the sal locus was also investigated in this study. There 
were two promoters identified, the salA and salKR promoters.  We initially 
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detected expression of the sal locus gene transcripts during growth in THY 
media. The salA promoter provides a read-through transcript for the entire locus. 
Although salKR promoter activity was observed at a very low level, the salKR 
genes would still be expressed through the salA promoter allowing SalK to be 
produced and present on the cell surface to sense its cognate signal. The salKR 
promoter is located within the salY gene and upstream of salKR providing 
differential regulation separate from the salA promoter. Thus SalKR can be 
independently produced under different conditions regulated by its own SalR 
repression in a feedback loop fashion. SalR demonstrated DNA binding activity 
towards its own promoter by specific binding to both upstream and downstream 
regions of the promoter. Moreover, the finding that salR gene expression 
increased ~50 fold after a 30 min exposure to human blood followed by an 
immediate decrease in expression to ~1 fold after 60 min of exposure [99] 
supports our hypothesis of a feedback loop repression by SalR to the salKR 
promoter. 
Notably, the identified SalR binding sites were not in close proximity to the 
-10 or -35 promoter regions of the salKR promoter. Therefore the repression was 
not due to interference with accessibility by RNA polymerase as described for 
other repressors such as LacI or LexA [142]. However, it has been shown that it 
is not necessary for repressors to bind within the promoter region to inhibit 
transcription. The CytR repressor binds at the -70 region upstream of the E. coli 
deo promoter and forms a complex with CRP resulting in inhibition of 
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transcription at this promoter [143]. The heat-stable nucleoid structure proteins 
(H-NS) were shown to form a tetrameric repression complex that causes DNA 
looping.  At the S. flexneri virF promoter, H-NS dimerizes at the -1 bp and -250 
bp, causing DNA bending through protein-protein interactions [144]. H-NS has 
also been shown to bind further downstream of the promoter creating a “Zip-up” 
mechanism of the DNA flanking the promoter and blocking transcription [145]. 
Furthermore, in the colicin bacteriocin locus, the Lex-A repressor binds directly to 
the operator region and represses transcription as a result of DNA bending [146, 
147]. Therefore, it is possible that the repression mechanism used by SalR could 
be alteration of DNA topology in the regions around the promoter preventing 
transcription initiation through the bending of DNA. The sophisticated regulation 
of the salKR promoter showed that the expression of salKR is tightly regulated 
and crucial for virulence. This may explain why we are unable to complement the 
salKR mutant phenotype by simply expressing salKR from a constitutive 
promoter on a plasmid. In addition, expression from a plasmid could result in 
overexpression of the proteins, which could also be problematic for regulation. 
The native promoter, along with the regulatory sites, is necessary for the precise 
transcription of the salKR promoter.  Further analysis is required to confirm that 
the mechanism used for repression by SalR is DNA bending through specific 
binding at identified sites on the salKR promoter.  
Repression of the salKR promoter was also influenced by salA. Even 
though the function of SalA as a lantibiotic is lost in the salivaricin locus of S. 
	   113	  
pyogenes, the data presented in this study suggest that SalA may function as an 
intracellular signaling molecule or possibly a co-repressor towards salKR 
promoter activity. Both SalA and SalKR have an additive effect on the repression 
of the salKR promoter. The absence of SalA in the salA-IFD strain increased 
adherence of S. pyogenes to macrophages suggesting that SalA, either directly 
or indirectly, also has an effect on the bacterial cell surface. SalKR was also 
shown to be involved in bacterial cell wall modification as demonstrated by the 
change in cytochrome C binding and resistance to lysozyme. Together, the data 
indicate the involvement of genes in sal locus in cell wall alteration in response to 
the host immune response. 
The data from this study also emphasized the importance of resident 
tissue macrophages in S. pyogenes adaptation to the host response. Previous 
reports have shown that at the early stages of invasive Group A streptococcal 
infection, the majority of the bacteria were localized intracellularly in 
macrophages [65]. After the disease progressed, both intracellular and 
extracellular bacteria were found at the tissue infection site [65]. We propose the 
following model for the role of the sal locus in systemic infection by S. pyogenes. 
As the skin surface is a normal reservoir for Group A streptococcus, breakage of 
the skin barrier will allow the bacteria to enter into the underlying tissues. 
Normally, the bacteria at the skin surface are at the stationary phase of growth 
due to the limiting nutrients on the skin surface.  SpeB is highly expressed at the 
site of infection as well as during stationary phase of S. pyogenes [65, 98]. Host 
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cell lysis by S. pyogenes cytolysins will allow bacteria access to nutrients.  SpeB 
can also act as a protease to cleave host antimicrobial LL-37 [98] as well as  
bacterial virulence factors, like M-protein [148, 149], which may facilitate 
phagocytosis by resident macrophages. Because the bacteria are resistant to 
killing by macrophages, the intracellular environment provides a safe haven for 
the bacteria to multiply as well as the signals to trigger upregulation of virulence 
gene expression that is required for systemic infection. After this mechanism of 
adaptation, extracellular bacteria could be observed as early as 4 hours after 
macrophage infection. These extracellular bacteria are more resistant to 
neutrophil killing, which allow bacteria to travel freely in the blood stream and 
disseminate to different sites of infection. During exposure of S. pyogenes to 
human blood, a strong increase in salR gene expression suggests another stage 
of adaptation. Both SalA and SalKR are involved with a cell wall modification 
process, which may play a role in the bacteria becoming more resistant to 
lysozyme from neutrophils. Taken together, the results of this study suggest that 
the salivaricin locus plays a key role in responding to the host environment by 
regulating genes required for survival in the host.  However, the role of SalKR as 
a two-component regulatory system requires further investigation to better 
understand the regulatory role of SalR during host-pathogen interactions and its 
contribution to the pathogenesis of S. pyogenes.  
In conclusion, it is not a surprise to find that the S. pyogenes lantibiotic 
locus functions are involved in virulence. Several other Gram-positive bacterial 
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pathogens also exploit a lantibiotic or bacteriocin locus to survive in a competitive 
environment during host-pathogen interactions. For example, the sag operon in 
S. pyogenes [20], the salKR system in S. suis [128], the Enterococcal cytolysin in 
E. faecalis [55, 135] and the Bsa bacteriocin locus in S. aureus [136] all have 
homology to lantibiotic/bacteriocin loci and are all implicated in virulence. In this 
study we demonstrated that the lantibiotic locus in S. pyogenes has clearly 
functionally evolved towards surviving in a competitive environment created by 
the host immune response. These results provide further evidence of the 
plasticity of bacteria, which are able to adapt and evolve to their environmental 
niche. In keeping with the emerging antibiotic resistant superbugs, resulting in 
high mortality and morbidity, the emergence of severe invasive bacteria has also 
become a growing threat in this past decade. Therefore, we are pitted in a race 
against constant bacterial evolution for a better understanding of their 
pathogenesis in an effort to develop more effective treatments and preventative 
care. 
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 The pathogenesis of Streptococcus pyogenes is due to its ability to 
overcome and adapt to the harsh environment created by the host immune 
response. The focus of this project was the SalKR two-component regulatory 
system, which facilitates bacterial adaptation by responding to environmental 
signals during host pathogen-interactions. The first goal of this project was to 
determine a role in virulence for the SalKR regulatory system. The complete 
deletion of the salKR genes in the wild type S. pyogenes strain HSC5 produced a 
highly attenuated mutant in a Zebrafish infection model. The ΔsalKR mutant 
appeared to lose the ability to survive in the blood stream, which consequently 
inhibited systemic dissemination to the spleen. The attenuation of the ΔsalKR 
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mutant in the blood stream was due to its sensitivity to intracellular and 
extracellular killing by neutrophils. This was most likely a consequence of the 
high susceptibility of the ΔsalKR mutant to cell lysis by lysozyme, attributable to 
the differences observed in cell wall modification between the wild type and the 
mutant. Our data suggests that this modification is SalKR dependent.  The SalKR 
system was also involved in a cellular adaptation process while residing 
intracellularly in macrophages resulting in greater resistance to neutrophil killing.  
 The second goal of this study was to identify the regulation of salKR gene 
expression.  Transcriptional analysis of the sal locus revealed that expression of 
the salKR genes are governed by two promoters, the salA promoter and the 
salKR promoter. SalR regulates its own promoter by binding directly to 
repression sites identified both upstream and downstream of the salKR promoter. 
The SalA peptide, encoded by the salA gene at the 5’ end of the sal locus also 
affected salKR promoter activity. Both the salA and salKR promoters showed 
increased promoter activity during exposure to human serum. Taken together, 
the data suggested the importance of the SalKR two component system in 
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